project_id,project_name,country_id,country_code,country_name,region_id,region_code,region_name,place_id,place_code,place_name
652,1000 jours,10,NE,Niger,,,,,,
1021,2019 DRC Ebola Epidemiology OCB,,,,,,,,,
1020,2019 DRC Ebola Epidemiology OCG,1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
1019,2019 DRC Ebola Epidemiology OCP,1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
974,2019 evaluation of the performance of two rapid diagnostic tests for malaria in Aweil  South Sudan during high and low transmission season,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
1011,2019 Intersectional DRC Ebola Epidemiology Coordinator,1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
296,2nd line drug resistance in HIV and 12-month outcome on 3rd line,14,KE,Kenya,,,,,,
296,2nd line drug resistance in HIV and 12-month outcome on 3rd line,15,MW,Malawi,,,,,,
387,821534 Wound Survey- OCP,1,CD,Congo - Kinshasa,,,,,,
426,9 months MDRTB regimen in Papua New Guinea,81,PG,Papua New Guinea,,,,,,
585,9 months MDRTB regimen in Papua New Guinea,81,PG,Papua New Guinea,,,,,,
509,A completer,285,400,Undefined Countries,,,,,,
548,A definir,10,NE,Niger,,,,,,
1046,A supprimer,,,,,,,,,
816,A UTILISER POUR PROCHAINE CONSULTATION OCP,9,TD,Chad,,,,,,
965,Abortion Complications MSF,,,,,,,,,
873,Abortion Complications R2HC,4,CF,Central African Republic,,,,,,
873,Abortion Complications R2HC,1,CD,Congo - Kinshasa,,,,,,
873,Abortion Complications R2HC,12,NG,Nigeria,,,,,,
873,Abortion Complications R2HC,5,SS,South Sudan,,,,,,
784,ABR support health unit MSF USA,30,US,United States,3377,US-33,New York,53,US-33-01,New York
826,ABR Task Force support,285,400,Undefined Countries,,,,,,
231,Active Case Finding for TB amongst elderly patients  Cambodia,19,KH,Cambodia,1525,KH-16,Phnom Penh,68,Phnom Penh,Phnom Penh
610,Active Case Finding for TB amongst elderly patients  Cambodia,19,KH,Cambodia,,,,,,
210,Activities unrelated to a specific course (training department),,,,,,,,,
211,Activities unrelated to a specific project,3,FR,France,,,,,,
185,Added value of using repeated measurements of CRP to determine discontinuation of antibiotics,285,400,Undefined Countries,,,,,,
457,Adjumani  carriage second and third round 2015  OCP,13,UG,Uganda,3232,UG-01,Adjumani,48,UG-01-01,Adjumani
138,Aetiology of childhood pneumonia  Mbarara  Uganda,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
596,Ageing on ART in Chiradzulu,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
313,Ageing on ART in Chiradzulu,15,MW,Malawi,,,,,,
630,An open-label  single arm study to provide additional information on safety and effectiveness of rVsV-ZEBOV,11,BF,Burkina Faso,,,,,,
630,An open-label  single arm study to provide additional information on safety and effectiveness of rVsV-ZEBOV,1,CD,Congo - Kinshasa,,,,,,
630,An open-label  single arm study to provide additional information on safety and effectiveness of rVsV-ZEBOV,31,CI,Cote d'Ivoire,,,,,,
630,An open-label  single arm study to provide additional information on safety and effectiveness of rVsV-ZEBOV,16,GN,Guinea,,,,,,
630,An open-label  single arm study to provide additional information on safety and effectiveness of rVsV-ZEBOV,161,GW,Guinea-Bissau,,,,,,
630,An open-label  single arm study to provide additional information on safety and effectiveness of rVsV-ZEBOV,12,NG,Nigeria,,,,,,
630,An open-label  single arm study to provide additional information on safety and effectiveness of rVsV-ZEBOV,60,SL,Sierra Leone,,,,,,
451,Analyse bedaquilline  Armenie,18,AM,Armenia,,,,,,
586,Analyse bedaquilline  Armenie,18,AM,Armenia,,,,,,
586,Analyse bedaquilline  Armenie,89,GE,Georgia,,,,,,
222,Analyse de l'impact des actions preventives et curatives de MSF-OCG,285,400,Undefined Countries,,,,,,
1060,Analyse des donnees du Test & Treat  Yambio  Sud Soudan pour publication,5,SS,South Sudan,2825,SS-10,West Equatoria,152,Yambio,Yambio
223,Analyse des methodes d'evaluations dans les zones non accessibles ou a acces limite  MSF-OCG,285,400,Undefined Countries,,,,,,
66,Analyse descriptive ARV/Bleomycine multicentrique  MSF-F,14,KE,Kenya,,,,,,
624,Analyse RDC Epicentre MSF,1,CD,Congo - Kinshasa,,,,,,
273,Analyses multicentriques des adolescents Pre AR et ART,285,400,Undefined Countries,,,,,,
870,Analysis of STI risk groups for targeted systematic screening,227,PH,Philippines,2312,PH-47,Metropolitan Manila,40,PH-47-01,Manila
870,Analysis of STI risk groups for targeted systematic screening,227,PH,Philippines,2312,PH-47,Metropolitan Manila,100,Tondo,Tondo
226,Analysis of the snake bite antivenom database  CAR,4,CF,Central African Republic,,,,,,
673,Angola GOARN support Yellow fever,98,AO,Angola,45,AO-11,Luanda,61,Luanda,Luanda
673,Angola GOARN support Yellow fever,98,AO,Angola,45,AO-11,Luanda,61,Luanda,Luanda
14,Annual Nutrition/Vaccination/Mortality survey  Koutiala  Mali,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
43,Antibiotic presciption habits in MSF-OCP hospital settings,285,400,Undefined Countries,,,,,,
827,Antibiotic prescription practices - GARDP,285,400,Undefined Countries,,,,,,
714,Antibiotic prophylaxis for prevention of cholera among household members,14,KE,Kenya,,,,,,
714,Antibiotic prophylaxis for prevention of cholera among household members,15,MW,Malawi,,,,,,
714,Antibiotic prophylaxis for prevention of cholera among household members,13,UG,Uganda,,,,,,
728,Antibiotic resistance amongst Amman surgery patients,23,JO,Jordan,1382,JO-02,Amman,25,JO-02-01,Amman
1002,Antivenom RCT preparation line - MI984,4,CF,Central African Republic,,,,,,
1002,Antivenom RCT preparation line - MI984,5,SS,South Sudan,,,,,,
769,Appui desk urgence OCP,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
704,Appui enquete mortalite maternelle et complication,285,400,Undefined Countries,,,,,,
866,AREE NERU  Nigeria  OCA  2018,12,NG,Nigeria,,,,,,
183,Article on maxillofacial surgery  MSF-F,23,JO,Jordan,,,,,,
491,ASAQ MDA effect on EVD transmission and severity,60,SL,Sierra Leone,,,,,,
637,Assessment and Response to Emergencies and Epidemics (AREE)  Nigeria 2017,12,NG,Nigeria,2092,NG-08,Borno,39,NG-08-01,Maiduguri
189,Assessment of HIV status missclassification in HIV positive cohorts  BI,,,,,,,,,
792,Aweil Malaria support to desk,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
793,Aweil Malaria support to desk,5,SS,South Sudan,,,,,,
272,Bacteriemia in pediatric hospital,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
580,Base de donnees intersection  strategies preventives  All OC  RCA,4,CF,Central African Republic,411,CF-02,Bangui,,,
580,Base de donnees intersection  strategies preventives  All OC  RCA,4,CF,Central African Republic,417,CF-08,Mambere-Kadei,,,
515,Base de donnees intersection  strategies preventives  All OC  RCA,4,CF,Central African Republic,,,,,,
799,Baseline mortality survey in adult HIV positive patients admitted to the Medical Wards in Beira Central Hospital - Beira - Mozambique,22,MZ,Mozambique,,,,,,
751,Baseline survey in Mosul Iraq,35,IQ,Iraq,1307,IQ-06,Arbil,24,IQ-06-01,Erbil
430,Best decontamination method for IS and GA,13,UG,Uganda,,,,,,
860,Bleu de methylene et paludisme,285,400,Undefined Countries,,,,,,
184,Brief report on epidemiology of infection of Syrian surgical patients in Jordan,23,JO,Jordan,,,,,,
60,Bulletin (suivi descriptif par mission)  Fuchia analysis  MSF-OCA,,,,,,,,,
606,Bulletin (suivi descriptif par mission)  Fuchia analysis  MSF-OCA,,,,,,,,,
614,Bulletin (suivi descriptif par mission)  Fuchia analysis  MSF-OCB,285,400,Undefined Countries,,,,,,
57,Bulletin (suivi descriptif par mission)  Fuchia analysis  MSF-OCB,,,,,,,,,
616,Bulletin (suivi descriptif par mission)  Fuchia analysis  MSF-OCBa,285,400,Undefined Countries,,,,,,
58,Bulletin (suivi descriptif par mission)  Fuchia analysis  MSF-OCBa,,,,,,,,,
612,Bulletin (suivi descriptif par mission)  Fuchia analysis  MSF-OCP,285,400,Undefined Countries,,,,,,
59,Bulletin (suivi descriptif par mission)  Fuchia analysis  MSF-OCP,,,,,,,,,
41,Buruli diagnostic score,,,,,,,,,
412,C- Enquete de mortalite  nutrition  vaccination - RCA/Bangassou - OCB,4,CF,Central African Republic,,,,,,
298,C- South Sudan Mortality 2013 OCB,5,SS,South Sudan,,,,,,
6,C - Cholera - Congo - Pointe Noir - Evaluation et surveillance - MSF-F -  -  -  -,132,CG,Congo - Brazzaville,554,CG-10,Pointe Noire,73,Pointe Noire,Pointe Noire
219,C - Cholera - Haiti -  - Case control study  transmission cholera - MSF-F -  -  -  -,7,HT,Haiti,1139,HT-01,Centre,,,
219,C - Cholera - Haiti -  - Case control study  transmission cholera - MSF-F -  -  -  -,7,HT,Haiti,1141,HT-03,L'Artibonite,,,
219,C - Cholera - Haiti -  - Case control study  transmission cholera - MSF-F -  -  -  -,7,HT,Haiti,1148,HT-10,Sud,,,
31,C - Diphteria - Nigeria - Kimba - Epidemiological description of a diphtheria outbreak - MSF-F -  -  -  -,12,NG,Nigeria,2092,NG-08,Borno,71,Kimba,Kimba
9,C - Hepatite E - Soudan du Sud - Batil - Case-cohort study - MSF-B -  -  -  -,5,SS,South Sudan,2822,SS-07,Upper Nile,109,Batil,Batil
24,C - Malaria - Niger - Madaoua and Bouza - Investigation of an increase in malaria cases - MSF-E -  -  -  -,10,NE,Niger,,,,,,
19,C - Malaria - Niger - Niamey - SMC Explo - MSF-E -  -  -  -,10,NE,Niger,,,,,,
27,C - Malaria - RDC - Bas Uele - Malaria survey - MSF-CH -  -  -  -,1,CD,Congo - Kinshasa,,,,,,
11,C - Measles - DCR -  - Measles Eastern DRC 2013 intersectional  - MSF-F - MSF-B - MSF-CH -  -,1,CD,Congo - Kinshasa,,,,,,
28,C - Measles - Nigeria - Katsina - Post Measles Vaccination Coverage Survey - MSF-F -  -  -  -,12,NG,Nigeria,2105,NG-21,Katsina,80,Katsina,Katsina
8,C - Measles - RCA - Abba - Investigation - MSF-F -  -  -  -,4,CF,Central African Republic,420,CF-11,Nana-Mambere,74,Abba,Abba
7,C - Measles - RCA - Bangui/Carnot/Paoua - Measles CAR 2012 - MSF-F -  -  -  -,4,CF,Central African Republic,411,CF-02,Bangui,,,
7,C - Measles - RCA - Bangui/Carnot/Paoua - Measles CAR 2012 - MSF-F -  -  -  -,4,CF,Central African Republic,417,CF-08,Mambere-Kadei,,,
7,C - Measles - RCA - Bangui/Carnot/Paoua - Measles CAR 2012 - MSF-F -  -  -  -,4,CF,Central African Republic,423,CF-14,Ouham-Pende,,,
18,C - Mortality - Tchad - Tissi/Goz Beida - Retrospective mortality survey - MSF-F -  -  -  -,9,TD,Chad,2947,TD-19,Sila,78,Beida,Beida
18,C - Mortality - Tchad - Tissi/Goz Beida - Retrospective mortality survey - MSF-F -  -  -  -,9,TD,Chad,2947,TD-19,Sila,77,Tissi,Tissi
20,C - Nutrition - Burkina Faso -  - MUAC article writing - MSF-F -  -  -  -,11,BF,Burkina Faso,218,BF-07,Centre,79,Ouagadougou,Ouagadougou
10,C - Pest - Madagascar - Tana - Set up surveillance for plague in Tana  - MSF-F -  -  -  -,6,MG,Madagascar,1763,MG-01,Antananarivo,75,Antananarivo,Antananarivo
1,C - Pian - Congo - Betou - Enquete de prevalence - MSF-F -  -  -  -,132,CG,Congo - Brazzaville,545,CG-01,Bouenza,72,Betou,Betou
218,C - Surveillance - Uganda - Bundibugyo - DRC Refugees in Bundibugyo camp  - MSF-F -  -  -  -,13,UG,Uganda,3236,UG-05,Bundibugyo,84,Bundibugyo,Bundibugyo
25,C - VVS - RDC - Nord et Sud Kivu - Evaluation des programmes psycho-sociaux - CICR -  -  -  -,1,CD,Congo - Kinshasa,,,,,,
676,Cabinet medical Niger,10,NE,Niger,,,,,,
547,Calais Migrants,3,FR,France,,,,,,
848,Cambodia HCV Prevalence Survey 2018,19,KH,Cambodia,1511,KH-02,Batdambang,113,Moung Ruessei,Moung Ruessei
808,Capitalisation des resultats - Utilisation Paquets de soins Preventifs - Toutes sections - OCP,285,400,Undefined Countries,,,,,,
379,Carnot Mortalite retrospective 2014,4,CF,Central African Republic,,,,,,
645,Case-control study for the evaluation of the protective efficacy of SMC (NE120),10,NE,Niger,2084,NE-08,Zinder,38,NE-08-05,Magaria
1023,Case fatality risk among EVD cases in Butembo  DRC,1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
342,Centre de recherche et d'enseignement sur les maladies tropicales negligees au Cameroun,45,CM,Cameroon,527,CM-02,Centre,105,Yaounde,Yaounde
339,Chad  Mortality  Refugees  CAR 2014,9,TD,Chad,,,,,,
871,Cholera- Surveillance & vacci cov-Hoima-Uganda-OCP-2018,13,UG,Uganda,3240,UG-09,Hoima,115,Hoima,Hoima
885,Cholera-Outbreak surveilance & Vacci coverage- Bauchi- Nigeria-2018-OCP,12,NG,Nigeria,2089,NG-05,Bauchi,116,Bauchi,Bauchi
375,Cholera  South Sudan  2014  OCP,5,SS,South Sudan,,,,,,
501,Cholera  Tanzania  Refugees  2015,80,TZ,Tanzania,,,,,,
551,Cholera RDT evaluation,285,400,Undefined Countries,,,,,,
864,Cholera RDT evaluation - study preparation (MI984),285,400,Undefined Countries,,,,,,
462,Cholera surveillance  Kenya  OCP,14,KE,Kenya,,,,,,
422,CIPHER,285,400,Undefined Countries,,,,,,
573,Clean Kids  OCP,10,NE,Niger,,,,,,
758,Cluster-randomized trial of ciprofloxacin as a response to a meningococcal meningitis epidemic,10,NE,Niger,,,,,,
186,Cluster randomized trial of IPTc strategies  Guekedou  Guinea,16,GN,Guinea,,,,,,
818,Cluster randomized trial on screening and treatment of children who are tuberulosis contacts (CAP-TB) -- Mbarara site,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
246,Co-administration of OCV and OPV : immunological and safety outcomes,1,CD,Congo - Kinshasa,,,,,,
521,CODE NON UTILISE,27,KG,Kyrgyzstan,,,,,,
475,Cohort neonates  South Sudan  Aweil  OCP,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,120,AM-01,Aragatsotn,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,121,AM-02,Ararat,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,122,AM-03,Armavir,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,123,AM-04,Erevan,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,124,AM-05,Gegharkunik,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,125,AM-06,Kotayk,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,126,AM-07,Lori,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,127,AM-08,Shirak,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,128,AM-09,Syunik,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,129,AM-10,Tavush,,,
94,Cohort of paediatric MDR-TB contacts  Armenia,18,AM,Armenia,130,AM-11,Vayots Dzor,,,
582,Cohorte survivants ebola  OCP,46,LR,Liberia,1608,LR-11,Montserrado,28,LR-11-01,Monrovia
520,Cohorte survivants ebola  OCP,46,LR,Liberia,,,,,,
360,Collecte echantillon pasteur  Mali  OCP,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
359,Collecte echantillon pasteur  Mbarara  OCP,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
44,Communication scientifique,3,FR,France,,,,,,
954,Community-based mortality surveillance system  Bama  Borno State  Nigeria  OCP  2018,12,NG,Nigeria,2092,NG-08,Borno,102,Bama,Bama
1068,Community nut/mort surveillance Herat  Afghanistan,93,AF,Afghanistan,12,AF-12,Hirat,148,Herat,Herat
245,Community surveillance  Syria  MSF-F,32,SY,Syria,,,,,,
82,Community surveillance for the MSF-OCG malaria program  Guinea,16,GN,Guinea,,,,,,
417,Community surveillance redemption  Ebola  OCG,46,LR,Liberia,,,,,,
862,Comparison of Ultrasound versus Chest X-ray for TB diagnosis in Papua New Guinea,81,PG,Papua New Guinea,2377,PG-15,National Capital District,114,Port Moresby,Port Moresby
137,Completion and presentation of results of PSYCa3-6,,,,,,,,,
311,Completion of article on diarrheal disease in Niger,10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
84,Completion of different malnutrition preventive stratgies trial  Niger,10,NE,Niger,,,,,,
81,Completion of Etiology of CNS infections in children  Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
121,Completion of laboratory based evaluation of slides and filter-paper for TB-DST PCR,13,UG,Uganda,,,,,,
197,Conception d'une formation decentralisee,3,FR,France,,,,,,
198,Conception d'une formation evaluation rapide nutionelle  MSF-F,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
842,consultant pool animation,285,400,Undefined Countries,,,,,,
40,Consultation envelope  MSF-OCA,285,400,Undefined Countries,,,,,,
37,Consultation envelope  MSF-OCB,83,BE,Belgium,194,BE-01,Bruxelles,5,BE-01-01,Bruxelles
39,Consultation envelope  MSF-OCBa,2,ES,Spain,845,ES-06,Cataluna,17,ES-06-01,Barcelona
38,Consultation envelope  MSF-OCG (XO400),76,CH,Switzerland,447,CH-08,Geneve,15,CH-08-01,Geneva
36,Consultation envelope  MSF-OCP,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
35,Controle de qualite tests diagnostics rapides - MSF-OCP,285,400,Undefined Countries,,,,,,
481,Coordination de l'activite de formation du centre de recherche de Mbarara,13,UG,Uganda,,,,,,
108,Cost-effectiveness analyses of different programatic options for nutritional programs,,,,,,,,,
446,Cost-effectiveness analyses with different RUF  PATH,,,,,,,,,
563,Country & Mission to be defined later - Resomal and ORS and malnutrition - OCG - 2016,285,400,Undefined Countries,,,,,,
986,Couverture CPS Moissala Tchad 2018 OCP,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
538,Couverture vaccinal Bangasso 2015  OCB,4,CF,Central African Republic,418,CF-09,Mbomou,90,Bangassou,Bangassou
357,Couverture vaccinale rougeole  Tchad  Mandalia  OCP  2014,9,TD,Chad,2932,TD-04,Chari-Baguirmi,86,Mandelia,Mandelia
423,Coverage Survey  MDM,3,FR,France,,,,,,
315,Coverage survey  Niger  MDM,10,NE,Niger,,,,,,
1006,Coverage survey for MoH oral cholera vaccination,10,NE,Niger,2080,NE-04,Maradi,81,Madarounfa,Madarounfa
389,Coverage survey OCV  Gambella  OCP,34,EG,Egypt,,,,,,
169,Cross-cultural validation of an outcome scale for mental health programs,24,CO,Colombia,,,,,,
169,Cross-cultural validation of an outcome scale for mental health programs,25,PS,Palestine  state of,,,,,,
88,Cross Sectional surveys for MSF-CH malaria program  Guinea,16,GN,Guinea,,,,,,
674,Data Analysis Yemen Review OCP,33,YE,Yemen,3532,YE-01,Adan,55,YE-01-01,Aden
474,Data extraction for Kenya trial  OCP,14,KE,Kenya,1455,KE-02,Bomet,,,
474,Data extraction for Kenya trial  OCP,14,KE,Kenya,1470,KE-17,Kisumu,,,
490,Decentralises - Afrique du Sud,3,FR,France,,,,,,
323,Decentralises - Belgique,83,BE,Belgium,,,,,,
326,Decentralises - Espagne,2,ES,Spain,,,,,,
324,Decentralises - Etat-Unis,30,US,United States,,,,,,
325,Decentralises - Suisse,76,CH,Switzerland,,,,,,
574,Decentralises Cameroun,45,CM,Cameroon,,,,,,
863,Decentralises Dubai,29,AE,United Arab Emirates,,,,,,
575,Decentralises Espagne,2,ES,Spain,,,,,,
854,Demandes courantes des missions,,,,,,,,,
706,Depenses batiment,3,FR,France,,,,,,
707,Depenses secretariat,3,FR,France,,,,,,
708,Depenses telecommunication,3,FR,France,,,,,,
709,Depenses transport hors projet,3,FR,France,,,,,,
783,Description de l'epidemie de cholera a Goma et evaluation du risque epidemique par aire de sante - RDC 2017,1,CD,Congo - Kinshasa,543,CD-08,Kivu,11,CD-08-06,Goma
742,Description de l'epidemie de rougeole au Tanganika - RDC 2017,1,CD,Congo - Kinshasa,541,CD-06,Katanga,9,CD-06-04,Tanganika
664,Description epidemiologique rougeole MSF OCG Katanga,1,CD,Congo - Kinshasa,541,CD-06,Katanga,141,Ankoro,Ankoro
664,Description epidemiologique rougeole MSF OCG Katanga,1,CD,Congo - Kinshasa,541,CD-06,Katanga,83,Kabalo,Kabalo
664,Description epidemiologique rougeole MSF OCG Katanga,1,CD,Congo - Kinshasa,541,CD-06,Katanga,142,Manono,Manono
171,Description of 5 OC activities using MSF typology,285,400,Undefined Countries,,,,,,
488,Description of pediatric patients presenting with signs of septic shock  Koutiala  Mali,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
1055,DESTRoy TB Mozambique,22,MZ,Mozambique,1962,MZ-06,Maputo,32,MZ-06-01,Maputo
136,Development and cross cultural validation of a screening tool for children aged 6 to 36 months (PSYCa 6-36),19,KH,Cambodia,,,,,,
136,Development and cross cultural validation of a screening tool for children aged 6 to 36 months (PSYCa 6-36),14,KE,Kenya,,,,,,
136,Development and cross cultural validation of a screening tool for children aged 6 to 36 months (PSYCa 6-36),13,UG,Uganda,,,,,,
228,Development and validation of pedagogic tools for monthly follow up of uncomplicated SAM by mothers,10,NE,Niger,,,,,,
439,Development of basic bacterio lab  BI,3,FR,France,,,,,,
1017,Development of database for Essential Emergency and Critical Care in IPD  Homa Bay  Kenya  OCP,14,KE,Kenya,1470,KE-17,Kisumu,136,Homa Bay,Homa Bay
879,Development of protocols for filovirus outbreak management with investigational products,285,400,Undefined Countries,,,,,,
107,Development of research proposal on MDR-TB trial (unitaid),,,,,,,,,
131,Development of surgical epidemiological projects for OCP's surgical program in Amman,23,JO,Jordan,,,,,,
1069,Diagnostic yield of Fujifilm TB-LAM in HIV-positive patients,,,,,,,,,
627,Documentation de la vaccination OCV au Malawi - Machinga district,15,MW,Malawi,2011,MW-12,Machinga,,,
627,Documentation de la vaccination OCV au Malawi - Machinga district,15,MW,Malawi,2023,MW-24,Phalombe,,,
627,Documentation de la vaccination OCV au Malawi - Machinga district,15,MW,Malawi,2027,MW-28,Zomba,,,
962,Documentation of cholera cases in Madarounfa  2018,,,,,,,,,
1039,Documentation of generative mechanism inside Ndhiwa project-Kenya,14,KE,Kenya,1461,KE-08,Homa Bay,112,Ndhiwa,Ndhiwa
367,Documentation of mortality among CAR Refugees in Cameroon,45,CM,Cameroon,,,,,,
368,Documentation of mortality among CAR Refugees in Chad,9,TD,Chad,,,,,,
631,Documentation of the preventive program in Madarounfa  Niger,10,NE,Niger,,,,,,
632,Documentation suivi et evaluation de la mise en place du vaccin OCV en Afrique,1,CD,Congo - Kinshasa,541,CD-06,Katanga,,,
632,Documentation suivi et evaluation de la mise en place du vaccin OCV en Afrique,1,CD,Congo - Kinshasa,542,CD-07,Kinshasa City,,,
632,Documentation suivi et evaluation de la mise en place du vaccin OCV en Afrique,1,CD,Congo - Kinshasa,543,CD-08,Kivu,,,
685,Documentation vaccination cholera Kinshasa  OMS,1,CD,Congo - Kinshasa,542,CD-07,Kinshasa City,10,CD-07-05,Kinshasa
923,DOUBLON 6 NE PAS UTILISER - Malawi  Chiradzulu  Monitoring of activities linked with the Cervix Cancer project - OCP,,,,,,,,,
956,DOUBLON NE PAS UTILISER - Community-based mortality surveillance system  Bama  Borno State  Nigeria  OCP  2018,,,,,,,,,
955,DOUBLON NE PAS UTILISER Community-based mortality surveillance system  Bama  Borno State  Nigeria  OCP  2018,,,,,,,,,
369,DRC  immunoprotection  OCV  8 month 14days  Kalemie  OCP,1,CD,Congo - Kinshasa,541,CD-06,Katanga,7,CD-06-02,Kalemie
178,Drug resistance TB cohort  Swaziland,17,SZ,Swaziland,,,,,,
480,Dystonic syndrome  RDC  OCG  2015,1,CD,Congo - Kinshasa,,,,,,
282,E-Response training course,285,400,Undefined Countries,,,,,,
966,Ebola  Epidemiologie terrain  Nord-Kivu  RDC  OCG  2018,1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
957,Ebola  Epidemiologie terrain  Nord-Kivu  RDC  OCP  2018,1,CD,Congo - Kinshasa,543,CD-08,Kivu,66,Beni,Beni
378,Ebola  Guinea  OCB 2014,16,GN,Guinea,,,,,,
421,Ebola  Guinea  OCP,16,GN,Guinea,,,,,,
444,Ebola  Guinee  Nzerekore  ALIMA,16,GN,Guinea,,,,,,
377,Ebola  Liberia  OCG  2014,46,LR,Liberia,,,,,,
442,Ebola  Monrovia Evaluation  contact tracing  ACF,46,LR,Liberia,,,,,,
991,Ebola dashbord DRC,1,CD,Congo - Kinshasa,543,CD-08,Kivu,66,Beni,Beni
991,Ebola dashbord DRC,1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
402,Ebola epi training  ebolataskforce  OCB,83,BE,Belgium,,,,,,
435,Ebola Freetown  mise en place de la collecte des donnees  OCG,60,SL,Sierra Leone,,,,,,
663,Ebola Initiative - Multiplex,285,400,Undefined Countries,,,,,,
668,Ebola Initiative data sharing platform,285,400,Undefined Countries,,,,,,
760,Ebola outbreak in DRC  support to vaccination with rVSV,1,CD,Congo - Kinshasa,,,,,,
400,Ebola preparedness in at risk countries  OCB,8,ML,Mali,,,,,,
1029,Ebola RCT Katwa (OCB),1,CD,Congo - Kinshasa,543,CD-08,Kivu,149,Katwa,Katwa
394,Ebola surveillance in non affected surrounding countries OCB,285,400,Undefined Countries,,,,,,
620,Ebola Survivor-Freetown-Monitoring-OCB,60,SL,Sierra Leone,,,,,,
388,Ebola task force  OCB,83,BE,Belgium,,,,,,
996,Ebola treatment RCT,1,CD,Congo - Kinshasa,543,CD-08,Kivu,66,Beni,Beni
996,Ebola treatment RCT,1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
1067,Ecare evaluation (TIC XMT20),,,,,,,,,
993,Ecriture articles bacteriemie Koutiala et Mbarara,8,ML,Mali,,,,,,
993,Ecriture articles bacteriemie Koutiala et Mbarara,13,UG,Uganda,,,,,,
310,Effectiveness of current cholera effluent treatment practices: Are we doing more harm than good?,9,TD,Chad,,,,,,
87,Effectiveness of mass pneumococcal conjugate vaccination  Mbarara   BI Innovation Fund,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
497,Effectiveness Same Day CD4 test / ART start  &  Analysis : Safe to stop CD4 count  UNITAID (via OCP),15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
778,Effectiveness Same Day CD4 test / ART start & Analysis : Safe to stop CD4 count - OCP,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
794,Efficacite vaccinale du vaccin oral Euvichol - < Screening method>,7,HT,Haiti,1148,HT-10,Sud,22,HT-10-02,Port-a-Piment
963,Efficacy and safety of fexinidazole in patients with Tb rhodesiense HAT - DNDi WP1,15,MW,Malawi,,,,,,
963,Efficacy and safety of fexinidazole in patients with Tb rhodesiense HAT - DNDi WP1,13,UG,Uganda,,,,,,
74,Efficacy study AS-AQ et DHA-PPQ vs AM-LM for treatment of uncomplicated malaria in children,10,NE,Niger,,,,,,
290,EID in nut/ped programme- support baseline data,8,ML,Mali,,,,,,
985,Elearning OCG  2019,285,400,Undefined Countries,,,,,,
689,Electrolytes in Monrovia  OCP,46,LR,Liberia,1608,LR-11,Montserrado,28,LR-11-01,Monrovia
1048,endTB-Q Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB with Fluoroquinolone Resistance,,,,,,,,,
988,endTB observational study OCA/OCG: Treatment of MDR-TB with regimens containing bedaquiline or delamanid,118,BY,Belarus,,,,,,
988,endTB observational study OCA/OCG: Treatment of MDR-TB with regimens containing bedaquiline or delamanid,27,KG,Kyrgyzstan,,,,,,
988,endTB observational study OCA/OCG: Treatment of MDR-TB with regimens containing bedaquiline or delamanid,21,MM,Myanmar (Burma),,,,,,
964,endTB observational study OCP: Treatment of MDR-TB with regimens containing bedaquiline or delamanid,18,AM,Armenia,,,,,,
964,endTB observational study OCP: Treatment of MDR-TB with regimens containing bedaquiline or delamanid,89,GE,Georgia,,,,,,
964,endTB observational study OCP: Treatment of MDR-TB with regimens containing bedaquiline or delamanid,14,KE,Kenya,,,,,,
1034,endTB: Concomitant and Extended use of Bedaquiline- and Delamanid-containing regimens: a Multi-Country Observational Study,,,,,,,,,
800,English RAREE  Ivory Coast  OCP,31,CI,Cote d'Ivoire,512,CI-01,Abidjan,16,CI-01-01,Abidjan
642,Enquete Bouza PPCSI Niger OCBA,10,NE,Niger,2082,NE-06,Tahoua,37,NE-06-04,Bouza
973,Enquete Connaissances Aptitudes et Pratiques (CAP) sur le recours 'acces aux soins de la population de  du district sanitaire de  Douentza Region Mopti  republique du Mali,8,ML,Mali,1891,ML-06,Mopti,108,Douentza,Douentza
220,Enquete CV rougeole et mortalite retrospective  Aketi  RDC   MSF-CH,1,CD,Congo - Kinshasa,544,CD-09,Orientale,138,Aketi,Aketi
845,Enquete de couverture CPS   Diffa  Niger,10,NE,Niger,2078,NE-02,Diffa,34,NE-02-01,Diffa
739,Enquete de couverture CPS et de couverture vaccinale multi antigene - Moissala Tchad,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
834,Enquete de couverture CPS et de couverture vaccinale Novembre 2017 - Moissala Tchad,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
844,Enquete de couverture CPS et Vaccinale  Bafata,161,GW,Guinea-Bissau,993,GW-01,Bafata,96,Bafata,Bafata
619,enquete de couverture CPS et vaccinale a Moissala -Tchad,9,TD,Chad,,,,,,
623,enquete de couverture CPS Koutiala 2015 Mali,8,ML,Mali,,,,,,
1050,enquete de couverture d'un progamme de depistage du cancer du col de l'uterus - Malawi,,,,,,,,,
716,Enquete de couverture et d'efficacite vaccinale rougeole - RDC -PROVINCE MANIEMA - 2016,1,CD,Congo - Kinshasa,543,CD-08,Kivu,12,CD-08-07,Maniema
972,Enquete de couverture vaccinale  de prevalence de la malnutrition et de mortalite retrospective. District Sanitaire de Madaoua  Region de Tahoua  Niger,10,NE,Niger,2082,NE-06,Tahoua,107,Madaoua,Madaoua
1044,Enquete de couverture vaccinale chez les enfants 0-12 mois dans un projet pilote d'immunisation a la naissance avec le DN-HepB dans la region du Hambol  Cote d'Ivoire,31,CI,Cote d'Ivoire,522,CI-11,Vallee du Bandama,99,Katiola,Katiola
843,Enquete de couverture vaccinale dans la region de la Lobaye  Centrafrique,4,CF,Central African Republic,416,CF-07,Lobaye,95,Lobaye,Lobaye
539,Enquete de couverture vaccinale multi antigene a Yida Sud Soudan,5,SS,South Sudan,2821,SS-06,Unity,82,Yida,Yida
893,Enquete de couverture vaccinale multi antigenes  Kidal  Mali,8,ML,Mali,1889,ML-04,Kidal,101,Kidal,Kidal
625,enquete de couverture vaccinale OCV et tetanos Maroua- Cameroun,45,CM,Cameroon,529,CM-04,Extreme-Nord,91,Maroua,Maroua
768,Enquete de couverture vaccinale Oral Cholera Vaccine 1er et 2eme dose en Haiti,7,HT,Haiti,1148,HT-10,Sud,22,HT-10-02,Port-a-Piment
1040,Enquete de couverture vaccinale rougeole-meningite a Maradi,10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
633,enquete de mortalite a Madaoua  Niger,10,NE,Niger,,,,,,
550,enquete de mortalite baseline a Boga Ituri RDC,1,CD,Congo - Kinshasa,,,,,,
337,Enquete de mortalite en RDC  Rutshuru  2014  OCP,1,CD,Congo - Kinshasa,543,CD-08,Kivu,85,Rutshuru,Rutshuru
653,Enquete de mortalite et couverture vaccinale Paoua  RCA,4,CF,Central African Republic,423,CF-14,Ouham-Pende,14,CF-14-02,Paoua
390,Enquete de mortalite retrospective  Monrovia  OCP,46,LR,Liberia,1608,LR-11,Montserrado,28,LR-11-01,Monrovia
544,Enquete de mortalite retrospective a Diffa  Niger,10,NE,Niger,,,,,,
1035,Enquete de mortalite retrospective et specifiques apres une epidemie de rougeole dans trois Zones de Sante du Haut-Lomami - Republique Democratique du Congo (RDC)retrospective,1,CD,Congo - Kinshasa,541,CD-06,Katanga,127,Haut Lomami,Haut Lomami
371,Enquete mort/nut  Kabalo  RDC  OCP  2014,1,CD,Congo - Kinshasa,,,,,,
693,Enquete multi-indicateurs Koutiala - Mise a l'echelle - OCP - Mali,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
16,Enquete nutritionnelle et de mortalite retrospective  RDV  Kabalo  OCP,1,CD,Congo - Kinshasa,541,CD-06,Katanga,83,Kabalo,Kabalo
791,Enquete nutritionnelle et de mortalite retrospectiveKananga   Kasai Cantral,1,CD,Congo - Kinshasa,539,CD-04,Kasai-Occidental,6,CD-04-01,Kananga
322,Enquete Nutritionnelle SQUEAC  Madarounfa  Niger,10,NE,Niger,2080,NE-04,Maradi,81,Madarounfa,Madarounfa
655,Enquete par telephone mobile sur la situation sanitaire des populations du Nord Cameroun et l'acces aux soins (CM137),45,CM,Cameroon,529,CM-04,Extreme-Nord,131,Fotokol,Fotokol
655,Enquete par telephone mobile sur la situation sanitaire des populations du Nord Cameroun et l'acces aux soins (CM137),45,CM,Cameroon,529,CM-04,Extreme-Nord,132,Mayo-Sava,Mayo-Sava
655,Enquete par telephone mobile sur la situation sanitaire des populations du Nord Cameroun et l'acces aux soins (CM137),45,CM,Cameroon,529,CM-04,Extreme-Nord,130,Mora,Mora
334,Enquete retrospective de mortalite a Magaria,10,NE,Niger,,,,,,
998,Enquete sur la Connaissances  Aptitudes  Pratiques (CAP) de la population sur la sante de la reproduction  Diffa  Region de Diffa  Niger,10,NE,Niger,2078,NE-02,Diffa,34,NE-02-01,Diffa
997,Enquete sur la Connaissances  Aptitudes  Pratiques (CAP) de la population sur la sante de la reproduction  Diffa  Region de Diffa  Niger,,,,,,,,,
999,Enquete sur la Connaissances  Aptitudes  Pratiques (CAP) de la population sur la sante de la reproduction  Diffa  Region de Diffa  Niger,,,,,,,,,
327,Enveloppe for P projects,,,,,,,,,
355,Enveloppe jours pour concept note malaria in pregnancy Mbarara  OCP,13,UG,Uganda,,,,,,
331,Enveloppe paludisme,285,400,Undefined Countries,,,,,,
332,Enveloppe vaccination,,,,,,,,,
416,Epi platform  Ebola  Monrovia  OCG/OCP,46,LR,Liberia,,,,,,
671,Epidemie Cholera - Addis Adeba - OCP,75,ET,Ethiopia,,,,,,
526,Epidemie de Cholera - Juba - Sud Soudan - 2015,5,SS,South Sudan,,,,,,
626,Epidemie de Cholera au Malawi - Lake Chilwa- Machinga District,15,MW,Malawi,,,,,,
638,Epidemie de Cholera en Zambie - Lusaka - One dose OCV documentation,96,ZM,Zambia,3566,ZM-05,Lusaka,59,ZM-05-01,Lusaka
486,Epidemie de meningite a meningocoques (NmC) a Dosso  Niger,10,NE,Niger,,,,,,
525,Epidemie rougeole 2015 Katanga Mise en commun des donnees en intersection MSF,1,CD,Congo - Kinshasa,,,,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2816,SS-01,Central Equatoria,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2817,SS-02,Eastern Equatoria,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2818,SS-03,Jungoli,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2819,SS-04,Lakes,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2821,SS-06,Unity,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2822,SS-07,Upper Nile,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2823,SS-08,Warap,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2824,SS-09,West Bahr-al-Ghazal,,,
892,Epidemio position in South Sudan - OCP,5,SS,South Sudan,2825,SS-10,West Equatoria,,,
147,Epidemiologic support to M&E teams in HIV/AIDS programs,,,,,,,,,
628,Epidemiologie meningite intersection Niger 2016,10,NE,Niger,,,,,,
191,Epidemiology course  MSF-OCP,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
690,EPILINK,3,FR,France,,,,,,
167,Epitryps support  Intersection,,,,,,,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,526,CM-01,Adamaoua,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,527,CM-02,Centre,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,528,CM-03,Est,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,529,CM-04,Extreme-Nord,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,530,CM-05,Littoral,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,532,CM-07,Nord,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,531,CM-06,Nord-Ouest,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,533,CM-08,Ouest,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,535,CM-10,Sud,,,
1030,Esaa Evaluation of snakes bites antivenom in Cameroon,45,CM,Cameroon,534,CM-09,Sud-Ouest,,,
1058,Essai vaccinal J&J dans la province du Nord-Kivu,,,,,,,,,
887,Estimation et geolocalisation de la population residant dans les districts sanitaire de Moissala et Bouna  Tchad 2018,9,TD,Chad,,,,,,
340,Ethiopie  Mortalite  Gambella  2014,75,ET,Ethiopia,879,ET-06,Gambela Peoples,65,Gambela,Gambela
500,Etude de portage du meningocoque C au Niger,10,NE,Niger,,,,,,
774,Etude HIV en population KZN- Afrique du Sud,20,ZA,South Africa,3556,ZA-04,KwaZulu-Natal,58,ZA-04-01,Eshowe
774,Etude HIV en population KZN- Afrique du Sud,20,ZA,South Africa,3556,ZA-04,KwaZulu-Natal,135,Mbomgolwane,Mbomgolwane
682,Etude Score 2 Buruli,45,CM,Cameroon,,,,,,
510,Evaluating the Impact of Safe and Dignified Burials in the West Africa Ebola Virus Crisis,285,400,Undefined Countries,,,,,,
782,Evaluation de 5 ans de Chimio-prevention du Paludisme Saisonnier dans le district sanitaire de Moissala  TCHAD,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
656,evaluation de la situation sanitaire lie au Paludisme -Bas Uele - RDC,1,CD,Congo - Kinshasa,,,,,,
891,Evaluation di derme artificiel a Drouillard  unite de grand brules  Port-au-Prince Haiti,7,HT,Haiti,1146,HT-08,Ouest,21,HT-08-01,Port-au-Prince
519,Evaluation du marqueur HNL  Koutiala  Mali,8,ML,Mali,,,,,,
103,Evaluation du string test pour le diagnostic TB chez l'enfant et l'adulte ne pouvant cracher  Mbarara,13,UG,Uganda,,,,,,
711,Evaluation du test CryptoPS pour le diagnostic des meningites a cryptocoque,14,KE,Kenya,,,,,,
568,Evaluation Ebola avec CRASH  OCP,,,,,,,,,
17,Evaluation impact SMC  Tchad  OCP,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
809,Evaluation implementation CPAP - Monrovia - Liberia - OCP,46,LR,Liberia,1608,LR-11,Montserrado,28,LR-11-01,Monrovia
724,Evaluation Nigeria  Borno,12,NG,Nigeria,2092,NG-08,Borno,39,NG-08-01,Maiduguri
681,Evaluation nutrition et mortalite - urgence Nigeria Borno state,12,NG,Nigeria,2092,NG-08,Borno,39,NG-08-01,Maiduguri
102,Evaluation of a chest-X ray TB tick-sheet  South Africa  BI,20,ZA,South Africa,,,,,,
489,Evaluation of brucellosis diagnostic tests,5,SS,South Sudan,,,,,,
823,Evaluation of brucellosis diagnostic tests,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
104,Evaluation of children in contact with TB patients  Mbarara,13,UG,Uganda,,,,,,
755,Evaluation of pLDH rapid diagnostic test for malaria in Niger (NE120),10,NE,Niger,2084,NE-08,Zinder,38,NE-08-05,Magaria
122,Evaluation of POC creatine test  Intersection,,,,,,,,,
30,Evaluation of SP+AQ resistance during SMC  Madarounfa  Niger,10,NE,Niger,2080,NE-04,Maradi,81,Madarounfa,Madarounfa
148,Evaluation of the feasibility of decentralised deployment of HIV POC tests  Malawi,15,MW,Malawi,,,,,,
106,Evaluation of the Small Membrane Filtration for diagnosis of pulmonary tuberculosis  Mbarara,13,UG,Uganda,,,,,,
156,Evaluation of weekly  monthly and single visit schedules of follow-up for the treatment of uncomplicated SAM,285,400,Undefined Countries,,,,,,
414,Evaluation screening tool  Ebola  OCP,46,LR,Liberia,,,,,,
78,Evaluation Securite et efficacite Monoxyde d'azote (NO)   BI,13,UG,Uganda,,,,,,
76,Evaluation Securite et efficacite Monoxyde d'azote (NO)  MSF-OCP,13,UG,Uganda,,,,,,
380,Explo  Ivory Coast  Ebola Surveillance  OCP,31,CI,Cote d'Ivoire,,,,,,
503,External services - ASTRO-CM,13,UG,Uganda,,,,,,
536,External services - Clean Air,13,UG,Uganda,,,,,,
535,External services - Health Fair study,13,UG,Uganda,,,,,,
535,External services - Health Fair study,285,400,Undefined Countries,,,,,,
828,External services - HPV,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
363,External services - META,13,UG,Uganda,,,,,,
504,External services - MUST pediatric pneumonia study,13,UG,Uganda,,,,,,
507,External services - Obstructed labor (UPIM neasted study),13,UG,Uganda,,,,,,
662,External services - Severe TB (MUST-UVA) - ICIDR,13,UG,Uganda,,,,,,
851,External services - TB biomarkers,13,UG,Uganda,,,,,,
506,External services - UPIM,13,UG,Uganda,,,,,,
505,External services - Wisepill,13,UG,Uganda,,,,,,
172,FACT Project  DNDI,46,LR,Liberia,1609,LR-12,Nimba,111,Nimba,Nimba
358,Facteurs associes aux retards aux rendez-vous - CARNOT,4,CF,Central African Republic,417,CF-08,Mambere-Kadei,13,CF-08-01,Carnot
238,Facteurs associes aux retards aux rendez-vous - CARNOT,4,CF,Central African Republic,,,,,,
776,Facteurs de risque de transmission du Cholera pendant l'epidemie au Yemen  2017,33,YE,Yemen,3540,YE-09,Amanat Al Asimah,56,YE-09-02,Sanaa
733,Feasibility  Acceptability and Efficacy of an active screening for sexual violence  - Kenya - Nairobi,14,KE,Kenya,1483,KE-30,Nairobi,27,KE-30-02,Nairobi
859,Feasibility of Neopenda (neonatal vital sign monitoring) in Cote d'Ivoire,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
629,Feasibility trial of the iTClamp,14,KE,Kenya,,,,,,
1009,Field epidemio position for Kenya and Uganda OCP,14,KE,Kenya,,,,,,
1009,Field epidemio position for Kenya and Uganda OCP,13,UG,Uganda,,,,,,
289,Field evaluation of innovative CD4 POC test(s)  UNITAID,15,MW,Malawi,,,,,,
448,Field trial of outpatient SAM treatment without systematic amoxicillan,10,NE,Niger,,,,,,
659,Fievre jaune RDC OCP investigation epidemie,1,CD,Congo - Kinshasa,,,,,,
144,Filariasis and onchcerciasis treatment needs in Central Africa (CAFRIFILON)  DNDi,,,,,,,,,
113,Fluid Management in Children in Shock with Underlying Severe Acute Malnutrition  OCG,9,TD,Chad,,,,,,
374,Follow up newborn  OCP,84,PK,Pakistan,,,,,,
374,Follow up newborn  OCP,285,400,Undefined Countries,,,,,,
590,Follow up newborn sepsis  Peshawar  OCP,84,PK,Pakistan,2223,PK-05,N.W.F.P.,120,Peshawar,Peshawar
13,Follow up OPD/IPD tool  MSF-OCP,14,KE,Kenya,,,,,,
13,Follow up OPD/IPD tool  MSF-OCP,15,MW,Malawi,,,,,,
13,Follow up OPD/IPD tool  MSF-OCP,13,UG,Uganda,,,,,,
967,Formation  pool d'urgence regional  Cote d'Ivoire 2019,31,CI,Cote d'Ivoire,512,CI-01,Abidjan,16,CI-01-01,Abidjan
970,Formation a l'evaluation rapide dans les urgences pour le staff des Philippines,227,PH,Philippines,,,,,,
969,Formation a l'evaluation rapide dans les urgences pour le staff des Philippines,,,,,,,,,
702,Formation des epidemios OCG aux enquetes de terrain (OPS),76,CH,Switzerland,447,CH-08,Geneve,15,CH-08-01,Geneva
884,Formation FOOT,,,,,,,,,
660,Formation FUCHIA - RCA  Bangui - OCB,4,CF,Central African Republic,411,CF-02,Bangui,97,Bangui,Bangui
254,Frais de fonctionnement a repartir,3,FR,France,,,,,,
597,Fuchia Maintenance & Support: v 1.7.1,285,400,Undefined Countries,,,,,,
244,Fuchia Maintenance & Support: v 1.7.1,,,,,,,,,
63,Fuchia monitoring  MSF-OCG,,,,,,,,,
611,Fuchia monitoring  MSF-OCG (XM300),285,400,Undefined Countries,,,,,,
484,Gambella  vaccination coverage PCV  2015  OCP,75,ET,Ethiopia,,,,,,
841,General epi support to NY OCP cell,7,HT,Haiti,,,,,,
841,General epi support to NY OCP cell,46,LR,Liberia,,,,,,
841,General epi support to NY OCP cell,5,SS,South Sudan,,,,,,
841,General epi support to NY OCP cell,82,SD,Sudan,,,,,,
176,Genotyping of DST strains  Swaziland,17,SZ,Swaziland,,,,,,
846,Goma LFU,1,CD,Congo - Kinshasa,543,CD-08,Kivu,11,CD-08-06,Goma
531,HCV Cambodia,19,KH,Cambodia,,,,,,
767,HCV Cambodia Laboratory studies UNITAID,19,KH,Cambodia,,,,,,
712,HCV Cambodia Validation of Xpert and serologic RDT,19,KH,Cambodia,,,,,,
534,HCV Training,19,KH,Cambodia,,,,,,
534,HCV Training,3,FR,France,,,,,,
15,Health environmental survey  RDC  MSF-OCP,1,CD,Congo - Kinshasa,542,CD-07,Kinshasa City,10,CD-07-05,Kinshasa
752,Health seeking Behaviour and mortality survey - Aweil town and county,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
302,Hepatite C (VHC)  UNITAID,285,400,Undefined Countries,,,,,,
406,Hepatitis C  Unitaid study  India OCA field,56,IN,India,1229,IN-21,Manipur,23,IN-21-01,Manipur
407,Hepatitis C  Unitaid study  India OCB field,56,IN,India,,,,,,
403,Hepatitis C  Unitaid study  Iran OCP field,55,IR,Iran,,,,,,
410,Hepatitis C  Unitaid study  Kenya OCB field,14,KE,Kenya,1483,KE-30,Nairobi,27,KE-30-02,Nairobi
408,Hepatitis C  Unitaid study  Mali OCP field,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
409,Hepatitis C  Unitaid study  Mozambique OCG field,22,MZ,Mozambique,1962,MZ-06,Maputo,32,MZ-06-01,Maputo
404,Hepatitis C  Unitaid study  Myanmar OCA field,21,MM,Myanmar (Burma),,,,,,
405,Hepatitis C  Unitaid study  Myanmar OCG field,21,MM,Myanmar (Burma),,,,,,
411,Hepatitis C  Unitaid study  transversal costs,19,KH,Cambodia,,,,,,
411,Hepatitis C  Unitaid study  transversal costs,56,IN,India,,,,,,
411,Hepatitis C  Unitaid study  transversal costs,14,KE,Kenya,,,,,,
411,Hepatitis C  Unitaid study  transversal costs,22,MZ,Mozambique,,,,,,
411,Hepatitis C  Unitaid study  transversal costs,21,MM,Myanmar (Burma),,,,,,
411,Hepatitis C  Unitaid study  transversal costs,13,UG,Uganda,,,,,,
461,Hepatitis C  Unitaid study  Uganda Mbarara field,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
424,Hepatitis C  Unitaid study  Ukraine OCB field,57,UA,Ukraine,,,,,,
230,Hepatitis C preliminary assessment  Cairo  Egypt,34,EG,Egypt,,,,,,
229,High dose RMP and ARV interaction study  Mbarara  ANRS,13,UG,Uganda,,,,,,
118,High dose RMP and ARV interaction study  Mbarara  MSF-OCP,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
833,HIV-ADO-DSD,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
836,HIV-Adolescents_Qualitative study,15,MW,Malawi,,,,,,
831,HIV-DTG-MOH-enhanced-monitoring,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
830,HIV-DTG-SWITCH-GUTU,282,ZW,Zimbabwe,3578,ZW-07,Masvingo,60,ZW-07-01,Gutu
667,HIV-Six month appointment analysis Malawi-OCP,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
351,HIV - Mise en place FUCHIA - Paoua,4,CF,Central African Republic,,,,,,
361,HIV 2nd line resistance and 3rd line outcomes  Mozambique (MZ160),22,MZ,Mozambique,1962,MZ-06,Maputo,32,MZ-06-01,Maputo
123,HIV impact in population survey  South Africa,20,ZA,South Africa,,,,,,
153,HIV joint modeling analysis  Malawi  Kenya  Uganda,,,,,,,,,
318,HIV Pediatric CIPHER Cohort,285,400,Undefined Countries,,,,,,
560,HIV Population Surveys  in Gutu and in Nsanje,15,MW,Malawi,2020,MW-21,Nsanje,,,
522,HIV prevalence survey -Kasese,13,UG,Uganda,3252,UG-21,Kasese,51,UG-21-04,Kasese
294,HIV/AIDS-EID-in nut/ped_ Support Baseline data & monitoring,8,ML,Mali,,,,,,
293,HIV/AIDS in Adolescents  Resistance and Adherence,15,MW,Malawi,,,,,,
780,HIV/AIDS in Adolescents  Resistance and Adherence - Malawi OCP,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
498,HIV/AIDS in Adolescents  Resistance and Adherence  UNITAID (via OCP),15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
569,HIV/AIDS in Adolescents_Qualitative study_UNITAID (via OCP),15,MW,Malawi,,,,,,
291,HIV/AIDS_Adolescents_Resistance and Adherence,15,MW,Malawi,,,,,,
743,HIV_2ndline_resistance_Uganda_OCP,13,UG,Uganda,3234,UG-03,Arua,49,UG-03-02,Arua
571,HIV2ndline_qualitative research on patients who failed 2nd ART,14,KE,Kenya,,,,,,
571,HIV2ndline_qualitative research on patients who failed 2nd ART,15,MW,Malawi,,,,,,
208,Holidays  sick leave  recuperation days (dates to be specified),3,FR,France,,,,,,
438,Hospital support Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
829,HPV Mass Vaccination Coverage Survey  Philippines,227,PH,Philippines,2312,PH-47,Metropolitan Manila,40,PH-47-01,Manila
247,Humanitarian situation and needs of Syrian refugees in Iraq-Kurdistan,35,IQ,Iraq,,,,,,
740,Identification des zones de sante les plus a risque d'epidemie de rougeole en 2017 en vue d'une vaccination preventive - RDC,1,CD,Congo - Kinshasa,541,CD-06,Katanga,8,CD-06-03,Katanga
621,IIEHSS Study  UNITAID  (via OCP),14,KE,Kenya,,,,,,
496,IIEHSS Study  UNITAID (via OCP),14,KE,Kenya,,,,,,
431,IIEHSS Study : Impact of Infant Expanded HIV Screening Strategy using Point Care EID in Ndhiwa  Kenya,14,KE,Kenya,,,,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3236,UG-05,Bundibugyo,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3237,UG-06,Bushenyi,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3240,UG-09,Hoima,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3241,UG-10,Iganga,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3243,UG-12,Kabale,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3244,UG-13,Kabarole,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3246,UG-15,Kalangala,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3247,UG-16,Kampala,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3249,UG-18,Kamwenge,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3250,UG-19,Kanungu,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3252,UG-21,Kasese,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3255,UG-24,Kibale,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3256,UG-25,Kiboga,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3257,UG-26,Kisoro,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3261,UG-30,Kyenjojo,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3265,UG-34,Luwero,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3266,UG-35,Masaka,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3267,UG-36,Masindi,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3270,UG-39,Mbarara,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3273,UG-42,Mpigi,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3274,UG-43,Mubende,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3275,UG-44,Mukono,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3277,UG-46,Nakasongola,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3279,UG-48,Ntungamo,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3282,UG-51,Rakai,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3283,UG-52,Rukungiri,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3284,UG-53,Sembabule,,,
643,IInvestigation of a Yellow Fever epidemic in Central and Western regions of Uganda 2016,13,UG,Uganda,3288,UG-57,Wakiso,,,
715,Immune response to a delayed second dose of killed whole cell oral cholera vaccine,7,HT,Haiti,,,,,,
822,Immune response to a delayed second dose of oral cholera vaccine (OCV) - Haiti,16,GN,Guinea,978,GN-02,Conakry,137,Conakry,Conakry
992,Immunogencity and Safety of Ad26.ZEBOV/MVA-BN-Filo,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
300,Immunogenecity of the OCV when used in a single dose regimen and under controlled temperature chain in Africa,285,400,Undefined Countries,,,,,,
454,Impact assessment on Stunting Prevention in Laos PDR,68,LA,Laos,,,,,,
852,Impact du programme d'antibiotique stewardship a l'hopital Drouillard  Haiti,7,HT,Haiti,1146,HT-08,Ouest,21,HT-08-01,Port-au-Prince
882,Impact evaluation of an oral cholera vaccination campaign in Goma  DRC.,1,CD,Congo - Kinshasa,,,,,,
321,Implementation d'une base de donnees orthopedique   Hopital Drouillard  Haiti,7,HT,Haiti,1146,HT-08,Ouest,21,HT-08-01,Port-au-Prince
307,Implementation of a trauma score and urban trauma mortality burden of disease study,,,,,,,,,
880,Improving surveillance in the context of a cholera outbreak in Nigeria,12,NG,Nigeria,,,,,,
576,Informatique,3,FR,France,,,,,,
713,Integrated PMTCT Maputo (MZ160),22,MZ,Mozambique,1962,MZ-06,Maputo,32,MZ-06-01,Maputo
734,Integrating partner self-testing strategy and Pre Exposure Prophylaxis into programs for pregnant and breastfeeding women - a feasibility study - Kenya,14,KE,Kenya,1461,KE-08,Homa Bay,26,KE-08-01,Homa Bay
975,Intensified tuberculosis treatment to reduce the high mortality of tuberculous meningitis in HIV-infected and uninfected patients,13,UG,Uganda,3243,UG-12,Kabale,,,
975,Intensified tuberculosis treatment to reduce the high mortality of tuberculous meningitis in HIV-infected and uninfected patients,13,UG,Uganda,3270,UG-39,Mbarara,,,
443,Intermittent Preventive Treatment for malaria with DHA-Piperaquine in a refugee camp,13,UG,Uganda,3232,UG-01,Adjumani,48,UG-01-01,Adjumani
485,Internal Training for OCBA (PPD),2,ES,Spain,845,ES-06,Cataluna,17,ES-06-01,Barcelona
989,Interpretation des donnees de mortalite,285,400,Undefined Countries,,,,,,
329,Intersection data analyses,4,CF,Central African Republic,,,,,,
661,Intoxication documentation Monrovia 2016,46,LR,Liberia,1608,LR-11,Montserrado,28,LR-11-01,Monrovia
762,Investigation d'une epidemie d'origine inconnue apres des funerailles au Liberia,46,LR,Liberia,1612,LR-15,Sinoe,133,Greenville City,Greenville City
763,Investigation d'une epidemie de cholera au Yemen,33,YE,Yemen,,,,,,
343,Investigation d'une epidemie de fievre hemorragique  Gueckedou  Guinee,16,GN,Guinea,984,GN-08,Nzerekore,89,Gueckedou,Gueckedou
530,Investigation de cas d'intoxication neonatales a l'hopital de Monrovia,46,LR,Liberia,1608,LR-11,Montserrado,28,LR-11-01,Monrovia
1052,investigation epidemie de Cholera Lubumbachi RDC,1,CD,Congo - Kinshasa,541,CD-06,Katanga,87,Lubumbashi,Lubumbashi
1051,investigation epidemie de Cholera Lubumbachi RDC,,,,,,,,,
1053,investigation epidemie de Cholera Lubumbachi RDC,,,,,,,,,
1054,investigation epidemie de Cholera Lubumbachi RDC,,,,,,,,,
650,Investigation epidemie de paludisme - bas et Haut Uele - province orientale-RDC,1,CD,Congo - Kinshasa,544,CD-09,Orientale,140,Bas Uele,Bas Uele
1004,Investigation Epidemie de rougeole  Haut Lomami  RDC,1,CD,Congo - Kinshasa,541,CD-06,Katanga,127,Haut Lomami,Haut Lomami
1045,Investigation epidemie de rougeole  meningite  nut N'djamena - Tchad - 2019,9,TD,Chad,2950,TD-22,Ville de N'Djamena,63,N'Djamena,N'Djamena
447,Investigational Ebola Vaccines  Guinea,16,GN,Guinea,,,,,,
599,IPD Homa Bay Epidemiology Support,14,KE,Kenya,1461,KE-08,Homa Bay,26,KE-08-01,Homa Bay
319,IPD Homa Bay Epidemiology Support,14,KE,Kenya,,,,,,
101,IPT feasibility study  Mathare,14,KE,Kenya,,,,,,
456,Jahun  OCP  Nigeria  2016,12,NG,Nigeria,,,,,,
570,Jordan - Irbid - Follow up of children - 2015,23,JO,Jordan,1385,JO-05,Irbid,121,Irbid,Irbid
45,Journee scientifique,3,FR,France,,,,,,
241,Kaposi - Analyse descriptive ARV/Bleomycine,14,KE,Kenya,,,,,,
1005,Laboratory Information Management System,10,NE,Niger,,,,,,
1005,Laboratory Information Management System,13,UG,Uganda,,,,,,
440,Laboratory Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
806,LAC  OCP/ CRASH  2018,3,FR,France,,,,,,
976,LAC LEAP  OCP  2019,285,400,Undefined Countries,,,,,,
427,LAM test for TB diagnosis in severely malnourished children,10,NE,Niger,,,,,,
257,Large-scale introduction of a new WHO pre-qualified disposable syringe needle-free injection device in the context of a preventive or reactive measles vaccination campaign,285,400,Undefined Countries,,,,,,
649,Large-scale introduction of a new WHO pre-qualified disposable syringe needle-free injection device in the context of a preventive or reactive measles vaccination campaign,285,400,Undefined Countries,,,,,,
761,Leadership Education Academic Partnership (LEAP),155,GB,United Kingdom,936,GB-01,England,20,GB-01-01,Manchester
1025,Literature Review of Antipsychotics,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
429,Living Study,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
478,Longitudinal cohort of EVD survivors  Freetown  Sierra Leone,60,SL,Sierra Leone,,,,,,
883,Lopinavir-based antiretroviral therapy (LOLIPOP),13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
858,Lusaka ocv campaign effectiveness studies - 2018,96,ZM,Zambia,3566,ZM-05,Lusaka,59,ZM-05-01,Lusaka
471,M&E activites VIH - Formation FUCHIA   Algerie  Annaba  OCB,70,DZ,Algeria,,,,,,
730,M&E of the Implementation and outcomes of EID with SAMBA II Arua Uganda,13,UG,Uganda,3234,UG-03,Arua,49,UG-03-02,Arua
472,M&E system for South Tehran clinic  Iran,55,IR,Iran,1298,IR-28,Tehran,88,Tehran,Tehran
316,Maintenance ePOP,285,400,Undefined Countries,,,,,,
73,Malaria-Nutrition  Mali et coordination paris  2014,8,ML,Mali,,,,,,
353,Malaria-Nutrition  Niger  BI  2014,10,NE,Niger,,,,,,
312,Malaria-Uganda-Mbarara-Transmission,13,UG,Uganda,,,,,,
718,Malaria data analysis aweil south sudan december 2016,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
666,Malaria efficacy study  Aweil and Yida  South Sudan,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
756,Malaria prevalence surveys (NE120),10,NE,Niger,2084,NE-08,Zinder,38,NE-08-05,Magaria
567,Malawi - Chiradzulu - FUCHIA databases - 2015-11,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
710,Malawi - Chiradzulu - Once a year appointment (OYA),15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
821,Malawi  Chiradzulu  Monitoring of activities linked with the Cervix Cancer project - OCP,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
853,Mapping of MSF R&D Projects  - DOUBLON,,,,,,,,,
798,Marburg surveillance - Kween- Uganda - OCP,13,UG,Uganda,3251,UG-20,Kapchorwa,94,Kween,Kween
835,Marqueurs genetiques de la resistance a la sulfadoxine-pyrimethamine et a l'amodiaquine apres 5 ans de chimio-prevention du paludisme saisonnier  district sanitaire de Moissala  Tchad 2018,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
600,Marqueurs genetiques de la resistance a la sulfadoxine-pyrimethamine et a l'amodiaquine apres deux annees de chimio prevention du paludisme saisonnier dans le district sanitaire de Moissala  Tchad,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
255,Marqueurs genetiques de la resistance a la sulfadoxine-pyrimethamine et a l'amodiaquine apres deux annees de chimio prevention du paludisme saisonnier dans le district sanitaire de Moissala  Tchad,9,TD,Chad,,,,,,
1008,Maternal and child care surveillance system Moissala  Tchad,,,,,,,,,
824,MDR-TB-sequencing project (MZ160),22,MZ,Mozambique,,,,,,
493,MDR-TB operational research  Kyrgystan  Belarus  India  Georgia  Armenia  Kenya  UNITAID EndTB(via OCP),18,AM,Armenia,,,,,,
493,MDR-TB operational research  Kyrgystan  Belarus  India  Georgia  Armenia  Kenya  UNITAID EndTB(via OCP),118,BY,Belarus,,,,,,
493,MDR-TB operational research  Kyrgystan  Belarus  India  Georgia  Armenia  Kenya  UNITAID EndTB(via OCP),89,GE,Georgia,,,,,,
493,MDR-TB operational research  Kyrgystan  Belarus  India  Georgia  Armenia  Kenya  UNITAID EndTB(via OCP),27,KG,Kyrgyzstan,,,,,,
493,MDR-TB operational research  Kyrgystan  Belarus  India  Georgia  Armenia  Kenya  UNITAID EndTB(via OCP),21,MM,Myanmar (Burma),,,,,,
299,MDR-TB operational research UNITAID,285,400,Undefined Countries,,,,,,
495,MDR-TB trial  Kirghizistan & Georgie  UNITAID (via OCP),27,KG,Kyrgyzstan,,,,,,
473,MDR -TB sequencing project,22,MZ,Mozambique,,,,,,
587,MDR -TB sequencing project,22,MZ,Mozambique,,,,,,
473,MDR -TB sequencing project,96,ZM,Zambia,,,,,,
587,MDR -TB sequencing project,96,ZM,Zambia,,,,,,
260,Measles and OPV vaccination coverage in North and South Kivu (DRC),1,CD,Congo - Kinshasa,543,CD-08,Kivu,11,CD-08-06,Goma
1041,Measles Outbreak - Maiduguri - MSF OCP,12,NG,Nigeria,2092,NG-08,Borno,39,NG-08-01,Maiduguri
470,Measles outbreak 2015  Yida  South Sudan   OCP,5,SS,South Sudan,,,,,,
328,Measles outbreak investigation  Ndjamena  Chad  2014,9,TD,Chad,2950,TD-22,Ville de N'Djamena,63,N'Djamena,N'Djamena
1065,Measles vaccination Coverage Survey  Chari Baguirmi,9,TD,Chad,2932,TD-04,Chari-Baguirmi,144,Ba-illi,Ba-illi
1065,Measles vaccination Coverage Survey  Chari Baguirmi,9,TD,Chad,2932,TD-04,Chari-Baguirmi,143,Bousso,Bousso
1065,Measles vaccination Coverage Survey  Chari Baguirmi,9,TD,Chad,2932,TD-04,Chari-Baguirmi,145,Konou,Konou
805,Med/Logs cellules  OCP,3,FR,France,,,,,,
365,Medical Care Under Fire  BI,285,400,Undefined Countries,,,,,,
502,Meningite  Niamey  Niger  OCG  2015,10,NE,Niger,2081,NE-05,Niamey,36,NE-05-03,Niamey
516,Meningite  Niger / Niamey  MSF-OCG  OCB  OCBa,10,NE,Niger,,,,,,
1026,Meningite Rougeole Tchad 2019,,,,,,,,,
1000,Meningitis surveillance Niger 2019,10,NE,Niger,2081,NE-05,Niamey,36,NE-05-03,Niamey
757,Meningitis vaccine effectiveness study  Niamey,10,NE,Niger,2081,NE-05,Niamey,36,NE-05-03,Niamey
790,Mental Health and NCD - Mosul IDPs - Iraq,35,IQ,Iraq,,,,,,
301,Meta-analyse des performances de la microscopie a fluorescence pour le diagnostic TB  OCP,285,400,Undefined Countries,,,,,,
4,Methodological support  MSF-OCBa,2,ES,Spain,,,,,,
855,Methodological support to OCBA,285,400,Undefined Countries,,,,,,
352,Methodological support to surgery studies  OCP,9,TD,Chad,,,,,,
678,Migrants Grece  OCP,163,GR,Greece,1009,GR-01,Aegean,,,
678,Migrants Grece  OCP,163,GR,Greece,1011,GR-03,Attica,,,
876,Migrants in Libya - Literature Review - OCP,70,DZ,Algeria,,,,,,
876,Migrants in Libya - Literature Review - OCP,9,TD,Chad,,,,,,
876,Migrants in Libya - Literature Review - OCP,34,EG,Egypt,,,,,,
876,Migrants in Libya - Literature Review - OCP,190,LY,Libya,,,,,,
876,Migrants in Libya - Literature Review - OCP,8,ML,Mali,,,,,,
876,Migrants in Libya - Literature Review - OCP,10,NE,Niger,,,,,,
876,Migrants in Libya - Literature Review - OCP,82,SD,Sudan,,,,,,
753,Migrants Paris  OCP,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
745,Mini-Lab developpement (STALAB),285,400,Undefined Countries,,,,,,
529,Mission explo sante environnement au Kirghizistan,27,KG,Kyrgyzstan,1501,KG-01,Batken,118,Batken,Batken
143,Modeling impact of Shishelweni  Swaziland HIV Program,17,SZ,Swaziland,,,,,,
680,modelisation d'epidemie d'hepatite E (MI984),9,TD,Chad,,,,,,
680,modelisation d'epidemie d'hepatite E (MI984),82,SD,Sudan,,,,,,
688,Modelisation risque epidemique Cholera -HAITI post ouragan 2016.,7,HT,Haiti,,,,,,
572,Module essai clinique  MPH MUST,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
990,Monitoring  evaluation  surveillance/Cadre de travail,,,,,,,,,
155,Monitoring & evaluation  (M&E)  plan for UNITAID  Chiradzulu  Malawi and Arua  Uganda,15,MW,Malawi,,,,,,
155,Monitoring & evaluation  (M&E)  plan for UNITAID  Chiradzulu  Malawi and Arua  Uganda,13,UG,Uganda,,,,,,
953,Monitoring and evaluation of the trauma project  Gaza Strip  2018,25,PS,Palestine  state of,2531,PS-01,Gaza Strip,146,Gaza Strip,Gaza Strip
952,Monitoring and Evaluation of the Typhoid Conjugated Vaccine in Zimbabwe,282,ZW,Zimbabwe,3573,ZW-02,Harare,70,Harare,Harare
89,Monitoring implementation of IPT for PLHIV  Swaziland,17,SZ,Swaziland,,,,,,
618,Monitoring implementation of IPT for PLHIV  Swaziland,17,SZ,Swaziland,,,,,,
773,Monitoring of non-communicable diseases (NCDs) activities in North Irak (Erbil project),35,IQ,Iraq,1307,IQ-06,Arbil,24,IQ-06-01,Erbil
90,Monitoring of the introduction of the GeneXpert,,,,,,,,,
330,Mortalite des refugies de RCA au Cameroun  MSF-CH,45,CM,Cameroon,528,CM-03,Est,,,
213,Mortalite maternelle  Cote d'Ivoire,31,CI,Cote d'Ivoire,512,CI-01,Abidjan,16,CI-01-01,Abidjan
469,Mortality and snake bites  Agok  Maioun  South Sudan  OCG,5,SS,South Sudan,2822,SS-07,Upper Nile,,,
235,Mortality and VC  Jonglei State  South Sudan,5,SS,South Sudan,2818,SS-03,Jungoli,62,Jonglei,Jonglei
335,Mortality surveillance  Uganda  Adjumani  OCP,13,UG,Uganda,3232,UG-01,Adjumani,48,UG-01-01,Adjumani
386,Mortality Survey  Gore  Chad  october 2014  OCP,9,TD,Chad,,,,,,
499,Mortality survey and surveillance  Maiduguri  Nigeria 2015,12,NG,Nigeria,2092,NG-08,Borno,39,NG-08-01,Maiduguri
1031,Mozambique Cyclone Idai 8019  OCP,22,MZ,Mozambique,1965,MZ-09,Sofala,33,MZ-09-02,Beira
696,Mozambique HIV DR,22,MZ,Mozambique,1962,MZ-06,Maputo,,,
696,Mozambique HIV DR,22,MZ,Mozambique,1966,MZ-10,Tete,,,
869,MSF-Funded: Cambodia HepC Prevalence Survey 2018,19,KH,Cambodia,1511,KH-02,Batdambang,113,Moung Ruessei,Moung Ruessei
677,MSF-OCB  support technique general  pool d'urgence,285,400,Undefined Countries,,,,,,
65,Multi-site evaluation of HIV RDT  BI,,,,,,,,,
159,Multicentric cohort analysis of children on ART  Chiradzulu/Mathare/Arua,14,KE,Kenya,,,,,,
159,Multicentric cohort analysis of children on ART  Chiradzulu/Mathare/Arua,15,MW,Malawi,,,,,,
159,Multicentric cohort analysis of children on ART  Chiradzulu/Mathare/Arua,13,UG,Uganda,,,,,,
1001,Multicentric double-blind randomized controlled trial of antivenoms for snakebite,,,,,,,,,
602,Multicentric MSF Drug resistant tuberculosis study  Intersection,285,400,Undefined Countries,,,,,,
91,Multicentric MSF Drug resistant tuberculosis study  Intersection,,,,,,,,,
797,Multidrug-resistant tuberculosis (MDR-TB) treatment and Hepatitis C,18,AM,Armenia,,,,,,
744,Multiplex - prospective sample collection Mbarara  Uganda,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
741,Multiplex work stream 4,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
766,Multiplex Workstream 2,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
546,Nablus 10 year review,25,PS,Palestine  state of,,,,,,
543,National Course on outbreak deteaction   investigation and control Iran WHO,55,IR,Iran,,,,,,
67,Ndhiwa HIV Impact in Population Survey (NIPS),14,KE,Kenya,,,,,,
604,Ndhiwa HIV Impact in Population Survey (NIPS),14,KE,Kenya,,,,,,
819,Ndhiwa HIV Impact in Population Survey 2018,14,KE,Kenya,1461,KE-08,Homa Bay,112,Ndhiwa,Ndhiwa
477,Ndhiwa Household enumeration,14,KE,Kenya,,,,,,
314,Ndhiwa PMTCT Impact Evaluation,14,KE,Kenya,,,,,,
950,Ndjamena malnutrition 2018 : monitoring and survey,9,TD,Chad,2950,TD-22,Ville de N'Djamena,63,N'Djamena,N'Djamena
305,Negative Pressure Wound Treatment (NPWT),,,,,,,,,
449,Neonatal Sepsis Trial,5,SS,South Sudan,,,,,,
333,New projects buffer,285,400,Undefined Countries,,,,,,
749,New strategies to improve TB diagnosis in children,,,,,,,,,
894,NICU Retrospective Study - Irbid Jordan,23,JO,Jordan,,,,,,
370,Niger Bouza OCBA enquetes mortalite plus,10,NE,Niger,,,,,,
562,Nigeria  Jahun  Obstetric  OCP  2016,12,NG,Nigeria,2102,NG-18,Jigawa,122,Jahun,Jahun
672,Nigeria Borno IDPs-Malnutrition-OCP,12,NG,Nigeria,2092,NG-08,Borno,39,NG-08-01,Maiduguri
994,Non-inferiority fractional doses trial for yellow fever vaccine,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
679,Non-inferiority trial of low dose Yellow Fever vaccine compared to dose (YEFE),14,KE,Kenya,,,,,,
679,Non-inferiority trial of low dose Yellow Fever vaccine compared to dose (YEFE),13,UG,Uganda,,,,,,
97,Non-Tuberculosis Mycobacterium infections  Cambodia,19,KH,Cambodia,,,,,,
617,Non-Tuberculosis Mycobacterium infections  Cambodia,19,KH,Cambodia,,,,,,
775,North Syria- IDPs-surveillance,32,SY,Syria,2911,SY-03,Ar Raqqah,45,SY-03-01,Ein Issa
317,Not in D2,1,CD,Congo - Kinshasa,,,,,,
476,Nutributter  Mali  OCP,8,ML,Mali,,,,,,
588,Nutributter  Mali  OCP,8,ML,Mali,,,,,,
788,Nutritional situation analysis and surveillance for Medecins Sans Frontieres in Yemen,33,YE,Yemen,3541,YE-10,Amran,57,YE-10-03,Amran
236,Nutritional survey and implmentation of nutritional surveillance  Aweil  South Sudan,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
124,Observance TB-HIV co-infection CARINEMO trial  MSF-OCG,22,MZ,Mozambique,,,,,,
875,OCB HCV M&E support,56,IN,India,,,,,,
875,OCB HCV M&E support,14,KE,Kenya,,,,,,
875,OCB HCV M&E support,84,PK,Pakistan,,,,,,
670,OCB HCV Test & treat India,56,IN,India,,,,,,
460,OCG freetown  follow up of survivor,60,SL,Sierra Leone,,,,,,
589,OCG freetown  follow up of survivor,60,SL,Sierra Leone,,,,,,
458,OCG Freetown mortality survey 20,60,SL,Sierra Leone,,,,,,
874,OCG HCV monitoring and research support,22,MZ,Mozambique,,,,,,
874,OCG HCV monitoring and research support,21,MM,Myanmar (Burma),,,,,,
874,OCG HCV monitoring and research support,57,UA,Ukraine,,,,,,
459,OCG sierra leone outreach activities Freetown,60,SL,Sierra Leone,,,,,,
1057,OCP  RCA  etat des lieux du monitoring des patients VIH (Carnot  Paoua  Bria),4,CF,Central African Republic,414,CF-05,Haute-Kotto,,,
1057,OCP  RCA  etat des lieux du monitoring des patients VIH (Carnot  Paoua  Bria),4,CF,Central African Republic,417,CF-08,Mambere-Kadei,,,
1057,OCP  RCA  etat des lieux du monitoring des patients VIH (Carnot  Paoua  Bria),4,CF,Central African Republic,423,CF-14,Ouham-Pende,,,
639,OCV one dose effectivness study in Lusaka  Zambia.,96,ZM,Zambia,3566,ZM-05,Lusaka,59,ZM-05-01,Lusaka
533,OCV vaccine coverage  Malawi,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
479,OCV vaccine coverage and surveillance  Malawi,15,MW,Malawi,,,,,,
578,Oedemes bilateraux  enfants hospitalises en pediatrie ou CRENI  OCP,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
514,Oedemes bilateraux  enfants hospitalises en pediatrie ou CRENI  OCP,90,MD,Moldova,,,,,,
53,Office Kampala  Epicentre Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
513,Omnigen TB  laboratory study,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
450,Omnigene,19,KH,Cambodia,,,,,,
115,Open cohort of children with suspected TB  Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
180,OR 11/16 - Antibiotic resistance amongst Amman surgery patients  BI Innovation Fund,23,JO,Jordan,,,,,,
372,Oral cholera vaccine effectiveness study in South Sudan  OCB  2014,5,SS,South Sudan,,,,,,
234,Oral Cholera Vaccine Guinea - Scientific Communication,,,,,,,,,
987,Oral Cholera Vaccine Using Control Temperature Chain: Protocol Development,13,UG,Uganda,3240,UG-09,Hoima,,,
987,Oral Cholera Vaccine Using Control Temperature Chain: Protocol Development,13,UG,Uganda,3252,UG-21,Kasese,,,
468,organization of key documents and other resources,3,FR,France,,,,,,
695,Ouganda surveillance evaluation initial Bidibidi,13,UG,Uganda,3289,UG-58,Yumbe,69,Yumbe,Yumbe
364,Outbreak investigation: cholera in Juba  South Sudan  2014.,5,SS,South Sudan,,,,,,
1064,"Outcome of cervical precancer treatment by thermo-ablation in a VIA-based ""screen and treat"" programme in 2 Malawi health districts supported by MSF.",15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
112,Outcomes of the first Multidrug Resistant Tuberculosis program  Kenya,14,KE,Kenya,,,,,,
608,Outcomes of the first Multidrug Resistant Tuberculosis program  Kenya,14,KE,Kenya,,,,,,
415,Outreach activities  Ebola  OCP,46,LR,Liberia,,,,,,
890,Paediatric Early Warning System (PEWS).  Score on admission as a tool to analyse mortality in PICU in low resource settings - Guinea Bissau,161,GW,Guinea-Bissau,995,GW-03,Bissau,104,Neonatal Intensive Care Unit (NICU) in Bissau Simao Mendes National Hospital,Neonatal Intensive Care Unit (NICU) in Bissau Simao Mendes National Hospital
271,Palu evaluation  cyscope OCP,285,400,Undefined Countries,,,,,,
356,Parasite clearance and molecular markers estimates associated with efficacy of Coartem in malaria patients in Ishongororo  Mbarara UGANDA,13,UG,Uganda,,,,,,
354,Parasitological efficacy and pharmacovigilance of SMC  5PC proposal,,,,,,,,,
152,Participation to mobile lab implementation  Koutiala  Mali,8,ML,Mali,,,,,,
46,Participation to various WG  intersection,285,400,Undefined Countries,,,,,,
47,Partnership fund,,,,,,,,,
221,Pathologies environnementales  MSF-OCG,285,400,Undefined Countries,,,,,,
227,PCV Vaccine coverage and monitoring  Yida  South Sudan,5,SS,South Sudan,2821,SS-06,Unity,82,Yida,Yida
95,PDR and MDR-TB : prospective cohort study  Armenia,18,AM,Armenia,,,,,,
142,Performance evaluation of syphilis RDT,285,400,Undefined Countries,,,,,,
877,Persistent fever Tabarakallah  Sudan,82,SD,Sudan,2693,SD-02,Al Qadarif,147,Tabarakallah,Tabarakallah
130,Phase III trial of BRV-PV rotavirus vaccine,10,NE,Niger,,,,,,
881,Phase IIIb rVSV vaccination in DRC (CD449),1,CD,Congo - Kinshasa,,,,,,
772,Physio scale Aman,23,JO,Jordan,1382,JO-02,Amman,25,JO-02-01,Amman
1033,PIPOC - Paediatric Infections Point-Of-Care. Point-of-care approach for Rapid and Easy Meningitis Diagnosis,,,,,,,,,
1049,PK sub study of endTB clinical trial Evaluating Newly approved Drugs for multidrug-resistant TB,,,,,,,,,
54,Plan de Formation  Mbarara,13,UG,Uganda,,,,,,
209,Plan de formation interne,3,FR,France,,,,,,
232,Plan strategique,3,FR,France,,,,,,
1062,Plan strategique,285,400,Undefined Countries,,,,,,
49,Plateforme Scientifique Maradi,10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
55,Plateforme Scientifique Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
51,Plateforme Scientifique Niamey,10,NE,Niger,2081,NE-05,Niamey,36,NE-05-03,Niamey
149,PMTCT B+  Chiradzulu  Malawi,15,MW,Malawi,,,,,,
779,POC  M&E  Impact  Feasibility  Outcome - OCP Malawi & Uganda,15,MW,Malawi,,,,,,
779,POC  M&E  Impact  Feasibility  Outcome - OCP Malawi & Uganda,13,UG,Uganda,,,,,,
492,POC  M&E  Impact  Feasibility  Outcome  - Unitaid (via OCP),15,MW,Malawi,,,,,,
492,POC  M&E  Impact  Feasibility  Outcome  - Unitaid (via OCP),13,UG,Uganda,,,,,,
665,POCUS  aweil  South Sudan  OCP,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
552,Population en situation precaire  fevrier 2016,,,,,,,,,
258,Populations en Situation Precaire  mars 2014,2,ES,Spain,,,,,,
432,Populations en Situation Precaire  mars 2015,3,FR,France,,,,,,
694,Populations en Situation Precaire  mars 2017,2,ES,Spain,845,ES-06,Cataluna,17,ES-06-01,Barcelona
280,Populations en Situation Precaire  septembre 2014,3,FR,France,,,,,,
433,Populations en Situation Precaire  septembre 2015,3,FR,France,,,,,,
699,Populations in precarious situation  St Prix  septembre 2017,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
555,Populations Situation Precaire  septembre 2016,,,,,,,,,
675,Post ROSE,10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
297,Pre-ART Multicentric Analysis of FUCHIA database,285,400,Undefined Countries,,,,,,
96,Predictors of defaulting in drug resistant TB patients  Armenia  OCP,18,AM,Armenia,,,,,,
657,PREP Mozambique  Beira  OCB,22,MZ,Mozambique,1965,MZ-09,Sofala,33,MZ-09-02,Beira
1059,preparation essai vaccinal J&J Nord Kivu,,,,,,,,,
840,Preparation for use of ciprofloxacin as a meningitis epidemic response  2018 season (MI984),10,NE,Niger,,,,,,
1037,Preparations for use of J&J vaccine in DRC,1,CD,Congo - Kinshasa,543,CD-08,Kivu,66,Beni,Beni
1037,Preparations for use of J&J vaccine in DRC,1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
1037,Preparations for use of J&J vaccine in DRC,1,CD,Congo - Kinshasa,543,CD-08,Kivu,11,CD-08-06,Goma
736,Prevalence brucellosis Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
524,Prevalence des marqueurs moleculaires de la resistance a la sulfadoxine-pyrimethamine et a l'amodiaquine  Magaria,10,NE,Niger,2084,NE-08,Zinder,38,NE-08-05,Magaria
747,Prevalence of major genotypic resistance among ART experienced individuals hospitalized with advanced HIV disease in Homa-Bay  Kenya,14,KE,Kenya,1461,KE-08,Homa Bay,26,KE-08-01,Homa Bay
746,Prevalence of major genotypic resistance among ART experienced individuals hospitalized with advanced HIV disease in Kinshasa,1,CD,Congo - Kinshasa,542,CD-07,Kinshasa City,10,CD-07-05,Kinshasa
86,Prevention and improved access through box delivery,,,,,,,,,
482,Program Monitoring for MUAC as admission and exit criteria,10,NE,Niger,,,,,,
838,Program support OCP (envelope),285,400,Undefined Countries,,,,,,
559,Programmatic Support to the MSF OCB HCV Program in Pakistan,84,PK,Pakistan,,,,,,
558,Programmatic Support to the MSF OCP HCV Program in Cambodia,19,KH,Cambodia,,,,,,
295,Proposed HIV/AIDS projects with UNITAID : Effectiveness Same Day CD4 test / ART start  &  Analysis : Safe to stop CD4 count,15,MW,Malawi,,,,,,
644,Prospective cohort study of snakebite victims (SS160),5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,43,SS-05-01,Agok
308,Prospective description of surgical burn mortality,7,HT,Haiti,,,,,,
592,Prospective description of surgical burn mortality Haiti OCP,7,HT,Haiti,1146,HT-08,Ouest,21,HT-08-01,Port-au-Prince
622,Protocol development - cluster-randomized trial of ciprofloxacin for meningitis prophyalxis during epidemics (MI984),10,NE,Niger,,,,,,
878,Protocol development for a mental health and NCD trial,57,UA,Ukraine,,,,,,
419,Protocol MEURI  Ebola,,,,,,,,,
812,PSP   Calafell  Fevrier 2018,2,ES,Spain,845,ES-06,Cataluna,17,ES-06-01,Barcelona
982,PSP  Calafell  fevrier 2019,2,ES,Spain,845,ES-06,Cataluna,150,Calafell,Calafell
810,PSP  decentralise Dakar  avril 2018  OCP-OCG,94,SN,Senegal,,,,,,
554,PSP  decentralise Dakar  FR  avril 2016  OCP-OCG,,,,,,,,,
698,PSP  decentralise Dakar  FR  avril 2017  OCP-OCG,94,SN,Senegal,2710,SN-01,Dakar,42,SN-01-01,Dakar
556,PSP  decentralise Kampala  Eng  oct-nov 2016  OCP-OCG,,,,,,,,,
700,PSP  decentralise Kampala  Eng  oct-nov 2017 OCP-OCG,13,UG,Uganda,3247,UG-16,Kampala,50,UG-16-03,Kampala
811,PSP  decentralise Kampala  Nov 2018  OCP-OCG,13,UG,Uganda,,,,,,
813,PSP  Mandres  Sept 2018,3,FR,France,,,,,,
978,PSP  regional Kampala Nov 2019,13,UG,Uganda,3247,UG-16,Kampala,50,UG-16-03,Kampala
979,PSP Mandres  sept. 2019,3,FR,France,898,FR-04,Ile-de-France,151,Mandres,Mandres
980,PSP regional Dakar  OCP-OCG-OCA  avril 2019,94,SN,Senegal,2710,SN-01,Dakar,42,SN-01-01,Dakar
512,PSP_Kampala_2015_Francais_OCGOCP,13,UG,Uganda,,,,,,
796,PSYCa 3-6 Follow up,,,,,,,,,
983,PWUD intervention Monitoring_OCG_Mozambique,22,MZ,Mozambique,1961,MZ-05,Maputo City,119,Chamanculo,Chamanculo
669,Qualitative study_HIV2ndline_Mozambique,22,MZ,Mozambique,,,,,,
850,Qualitative support to the Access Campaign (IEXMED),285,400,Undefined Countries,,,,,,
52,R - General - Niger -  - Follow-up of research studies in Niger and coordination support - Princeton -  -  -  -,10,NE,Niger,,,,,,
50,R - General - Niger - Maradi/Niamey - Scientific Platform - MSF-N -  -  -  -,10,NE,Niger,2080,NE-04,Maradi,,,
50,R - General - Niger - Maradi/Niamey - Scientific Platform - MSF-N -  -  -  -,10,NE,Niger,2081,NE-05,Niamey,,,
56,R - HIV / AIDS - All -  - Appui Methodo general - MSF-F -  -  -  -,,,,,,,,,
61,R - HIV / AIDS - All -  - Combined analysis of virological M-studies - MSF-F -  -  -  - MSF-E,14,KE,Kenya,,,,,,
61,R - HIV / AIDS - All -  - Combined analysis of virological M-studies - MSF-F -  -  -  - MSF-E,15,MW,Malawi,,,,,,
61,R - HIV / AIDS - All -  - Combined analysis of virological M-studies - MSF-F -  -  -  - MSF-E,20,ZA,South Africa,,,,,,
62,R - HIV / AIDS - All -  - Fuchia maintenance & support: v 1.7.0 - MSF-F - MSF-B - MSF-CH - MSF-H - MSF-E,,,,,,,,,
125,R - HIV / AIDS - All -  - Mobile health technology - MSF-N -  -  -  -,,,,,,,,,
64,R - HIV / AIDS - All -  - Multicentric data analysis of compiled FUCHIA databases  - MSF-F - MSF-B - MSF-CH - MSF-H - MSF-E,285,400,Undefined Countries,,,,,,
240,R - HIV / AIDS - code a supprimer,15,MW,Malawi,,,,,,
166,R - HIV / AIDS - Malawi -  - Malawi Research Base Initial discussions - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
68,R - HIV / AIDS - Malawi - Chiradzulu - Chiradzulu HIV Impact in Population Survey (CHIPS) - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
151,R - HIV / AIDS - Malawi - Chiradzulu - Field evaluation of innovative HIV POC tests  - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
129,R - HIV / AIDS - Malawi - Chiradzulu - OYA Study - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
150,R - HIV / AIDS - Malawi - Chiradzulu - Quantifying linkage to care in CHIPS - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
146,R - HIV / AIDS - Malawi - Chiradzulu - Validation of task shifting model for HIV POC operation - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
157,R - HIV / AIDS - Malawi/Kenya/Uganda -  - Analysis of pre-ART outcomes of paediatric patients  - MSF-F -  -  -  -,14,KE,Kenya,,,,,,
157,R - HIV / AIDS - Malawi/Kenya/Uganda -  - Analysis of pre-ART outcomes of paediatric patients  - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
157,R - HIV / AIDS - Malawi/Kenya/Uganda -  - Analysis of pre-ART outcomes of paediatric patients  - MSF-F -  -  -  -,13,UG,Uganda,,,,,,
175,R - HIV / AIDS - Mozambique - Maputo - Pediatric Cohort Analysis - MSF-CH -  -  -  -,22,MZ,Mozambique,,,,,,
71,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Analyses - MSF-F -  -  -  -,14,KE,Kenya,,,,,,
71,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Analyses - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
71,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Analyses - MSF-F -  -  -  -,13,UG,Uganda,,,,,,
69,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Multicentric cohort analysis of Paediatric HIV programmes from entry - MSF-F -  -  -  -,14,KE,Kenya,,,,,,
69,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Multicentric cohort analysis of Paediatric HIV programmes from entry - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
69,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Multicentric cohort analysis of Paediatric HIV programmes from entry - MSF-F -  -  -  -,13,UG,Uganda,,,,,,
70,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Resistance patterns in second line failing patients - MSF-F -  -  -  -,14,KE,Kenya,,,,,,
70,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Resistance patterns in second line failing patients - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
70,R - HIV / AIDS - Uganda-Kenya-Malawi -  - Resistance patterns in second line failing patients - MSF-F -  -  -  -,13,UG,Uganda,,,,,,
243,R - HIV / AIDS  - Fuchia Maintenance & Support: v 1.7.1 - MSF-F - MSF-B - MSF-CH - MSF-H - MSF-E,,,,,,,,,
168,R - Malaria -  -  - Methological support for evaluation of cost-effectiveness of seasonal malaria chemoprophylaxis program - MSF-F -  -  -  -,,,,,,,,,
109,R - Malaria - Myanmar -  - Protocol development - MSF-CH -  -  -  -,21,MM,Myanmar (Burma),,,,,,
177,R - Malaria - Soudan du Sud - Yambio - Efficacy of ASAQ and AL for uncomplicated childhood malaria  - MSF-E -  -  -  -,5,SS,South Sudan,,,,,,
75,R - Malaria - Tchad - Moissala - Resistance SP+AQ - MSF-F -  -  -  -,9,TD,Chad,,,,,,
140,R - Malaria - Uganda - Mbarara - Entomology survey - MSF-F -  -  -  -,13,UG,Uganda,,,,,,
77,R - Malaria - Uganda - Mbarara - Evaluation Securite et efficacite Monoxyde d'azote (NO) - MGH -  -  -  -,13,UG,Uganda,,,,,,
141,R - Malaria - Uganda - Mbarara - Microfluo Malaria - MSF-F -  -  -  -,13,UG,Uganda,,,,,,
154,R - MCH - All -  - Cholera in pregnancy - MSF-CH -  -  -  -,,,,,,,,,
110,R - Nutrition - Mali - Koutiala - Methodological and technical support - MSF-F -  -  -  -,8,ML,Mali,,,,,,
127,R - Nutrition - Niger -  - Strategies to prevent malnutrition: food supplements vs cash transfer - MSF-F -  -  -  -,10,NE,Niger,,,,,,
128,R - Nutrition - Niger -  - Strategies to prevent malnutrition: food supplements vs cash transfer - WFP -  -  -  -,10,NE,Niger,,,,,,
85,R - Nutrition - Niger - Maradi - Risk factors of death of acute malnutrition in TFC and cause of morbidity - MSF-F -  -  -  -,10,NE,Niger,,,,,,
111,R - Nutrition - Niger - Niamey - Methodological and technical support - MSF-F -  -  -  -,10,NE,Niger,,,,,,
160,R - Pediatrics -  -  - RONI data monitoring and analysis - MSF-F -  -  -  -,,,,,,,,,
139,R - Schistosomoses - Madagascar - Beily - MADABIL - MSF-F -  -  -  -,6,MG,Madagascar,,,,,,
182,R - Surgery - Haiti -  - Long term follow up of internal fixation - MSF-F -  -  -  -,7,HT,Haiti,,,,,,
133,R - Surgery - Haiti -  - Post earthquake follow up in OCP Haiti orthopaedic surgery programs from Jan 2010-April 2010 - MSF-F -  -  -  -,7,HT,Haiti,,,,,,
179,R - Surgery - Haiti -  - Surgical site infection - MSF-F -  -  -  -,7,HT,Haiti,,,,,,
181,R - Surgery - Jordanie - Amman - CRP and Post surgery antibiotic use in Amman - MSF-F -  -  -  -,23,JO,Jordan,,,,,,
134,R - Surgery - Nigeria - Port Harcourt - Port Harcourt 2009-2011 retrospective data analysis  - MSF-F -  -  -  -,12,NG,Nigeria,,,,,,
98,R - TB - Georgia -  - PDR and MDR-TB: prospective cohort study - MSF-F -  -  -  -,89,GE,Georgia,951,GE-12,Tbilisi,64,Tbilisi,Tbilisi
187,R - TB - Kirghizistan -  - Evaluation projet TB dans les prisons - MSF-CH -  -  -  -,27,KG,Kyrgyzstan,,,,,,
126,R - TB - Malawi - Chiradzulu - The Effect of Isoniazid Preventive Therapy on Mortality and TB Incidence Among HIV Exposed Infants  - MSF-F -  -  -  -,15,MW,Malawi,,,,,,
105,R - TB - Uganda - Mbarara - Evaluation of the Small Membrane Filtration for diagnosis of pulmonary tuberculosis - BI -  -  -  -,13,UG,Uganda,,,,,,
116,R - TB - Uganda - Mbarara - Rifatox study - MSF-F -  -  -  -,13,UG,Uganda,,,,,,
117,R - TB - Uganda - Mbarara - Support to the TB program in Mbarara district - MSF-F -  -  -  -,13,UG,Uganda,,,,,,
163,R - Trypano -  -  - Epitryps multicentric: description of stage 1 - MSF-CH -  -  -  -,,,,,,,,,
164,R - Trypano -  -  - Outcomes of stage two Human African Trypanosomiasis (HAT) relapses treated with melarsoprol - MSF-CH -  -  -  -,,,,,,,,,
162,R - VPD -  -  - Protocol development MenAfriVac - MSF-F -  -  -  -,285,400,Undefined Countries,,,,,,
80,R - VPD - Malawi - Chiradzulu - HIV and Measles serologic study - MSF-F -  -  -  -,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
42,R - VPD - Niger - Maradi - Rotavirus epidemiology and vaccine study - MSF-F - MSF-B - MSF-CH -  - MSF-E,10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
511,Randomised non-inferiority trial of two snake antivenoms,4,CF,Central African Republic,423,CF-14,Ouham-Pende,14,CF-14-02,Paoua
995,Randomized trial of triple ACTs vs traditional ACTs for uncomplicated malaria in Niger (DeTACT)),10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
425,RAPID trial protocol development  Wellcome Trust,,,,,,,,,
764,RAREE Cote d'Ivoire  OCP,31,CI,Cote d'Ivoire,512,CI-01,Abidjan,16,CI-01-01,Abidjan
820,RCA  Carnot  Evaluation des patients VIH decentralises - OCP,4,CF,Central African Republic,417,CF-08,Mambere-Kadei,13,CF-08-01,Carnot
832,RDC  Goma  Proportion elevee de patients VIH perdus de vue - OCP,1,CD,Congo - Kinshasa,543,CD-08,Kivu,11,CD-08-06,Goma
951,RDC Beni 2018 Ebola Surveillance and Contact tracing,1,CD,Congo - Kinshasa,543,CD-08,Kivu,66,Beni,Beni
648,RDC Fievre jaune OCB 2016,1,CD,Congo - Kinshasa,,,,,,
748,Reduced follow-up study  Harvard,12,NG,Nigeria,,,,,,
968,Regional Emergency Pool Training  Cote d'Ivoire,,,,,,,,,
686,Renforcement des capacites - Elsevier,10,NE,Niger,,,,,,
518,Renforcement des capacites du centre de recherche au Niger (plan strategique),10,NE,Niger,,,,,,
545,Rep Epi Niger  ALIMA,10,NE,Niger,,,,,,
804,RepEpi  OCP  2018,,,,,,,,,
886,RepEpi IRD Guinee  2018,16,GN,Guinea,978,GN-02,Conakry,137,Conakry,Conakry
802,RepEpi Liberia  OCP  2018,46,LR,Liberia,,,,,,
865,RepEpi Niger  OCG  2018,10,NE,Niger,,,,,,
981,Reponse aux epidemies  anglais  mars 2019,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
557,Reponse aux epidemies  en francais  decembre 2016,,,,,,,,,
701,Reponse aux epidemies  en francais  decembre 2017,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
200,Reponse aux epidemies  Soudan  MSF-OCP,5,SS,South Sudan,,,,,,
801,Reponse aux epidemies anglais  mars 2018,3,FR,France,,,,,,
971,Reponse aux epidemies de rougeole au Katanga,,,,,,,,,
283,Reponse aux epidemies decentralisees  Nigeria  OCP,3,FR,France,,,,,,
279,Reponse aux epidemies en Anglais  fevrier 2014,3,FR,France,,,,,,
428,Reponse aux epidemies en Anglais  fevrier 2015,3,FR,France,,,,,,
692,Reponse aux epidemies en anglais  fevrier 2017,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
553,Reponse aux epidemies en anglais  mars 2016,,,,,,,,,
281,Reponse aux epidemies en Francais  decembre 2014,3,FR,France,,,,,,
434,Reponse aux epidemies en Francais  decembre 2015,3,FR,France,,,,,,
1047,Reponse aux epidemies en Haiti  OMS  2019,7,HT,Haiti,1146,HT-08,Ouest,21,HT-08-01,Port-au-Prince
786,Reponse aux epidemies francais  decembre 2018,3,FR,France,,,,,,
436,Reponse aux urgences  PUC Kinshasa  OCB,1,CD,Congo - Kinshasa,,,,,,
977,Reponses aux epidemies  Fr  dec.2019,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
373,Reseau de resistance a l'artemisinine proposal  OCP,,,,,,,,,
697,Responding to emergencies and epidemics (REE) Afgha  OCB  march 2017,93,AF,Afghanistan,14,AF-14,Kabul,2,AF-14-01,Kabul
731,Responding to emergencies and epidemics (REE) Sudan  OCG (SD295),82,SD,Sudan,2698,SD-07,Khartoum,41,SD-07-01,Khartoum
636,Responding to epidemics Iran,55,IR,Iran,,,,,,
385,Response to Emergencies  Khartoum  2014  OCG,82,SD,Sudan,,,,,,
336,Response to emergencies and to epidemics  Islamabd  Pakistan  OCB,84,PK,Pakistan,,,,,,
759,Retrospective analysis of 10 years of Amman Reconstructive Surgical Program,33,YE,Yemen,3541,YE-10,Amran,57,YE-10-03,Amran
727,Retrospective analysis of 2 years data in Aden (yemen) trauma Center 2015-2016,33,YE,Yemen,3532,YE-01,Adan,55,YE-01-01,Aden
344,Retrospective Mortality & VC  Minkaman South Soudan  OCG,5,SS,South Sudan,,,,,,
729,Retrospective mortality survey  Magaria 2017,10,NE,Niger,2084,NE-08,Zinder,38,NE-08-05,Magaria
441,Review and writing of scientific publication  Ebola,,,,,,,,,
384,Review of coverage methods - ACF,3,FR,France,,,,,,
867,Revision 2018 PSP,3,FR,France,898,FR-04,Ile-de-France,,,
723,Revision de la typologie  BI,285,400,Undefined Countries,,,,,,
635,Revision PSP,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
984,Revision PSP  2019,285,400,Undefined Countries,,,,,,
754,Revue de collecte des donnees Amman  OCP,23,JO,Jordan,1382,JO-02,Amman,25,JO-02-01,Amman
817,Rifashort Persister Study -- Substudy of Rifashort Trial,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
549,RIFASHORT_ international TB trial,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
737,Rift Valley Fever investigation,10,NE,Niger,,,,,,
72,Risk factors for visceral leishmaniasis,,,,,,,,,
789,Rohingya Emergency-Bangladesh-OCP-2017,95,BD,Bangladesh,226,BD-02,Chittagong,4,BD-02-01,Ukhia
120,Rotavirus surveillance in malnourished children,10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
532,Rougeole  RDC  OCG  Katanga,1,CD,Congo - Kinshasa,541,CD-06,Katanga,8,CD-06-03,Katanga
517,Rougeole  RDC Katanga  2015  OCP,1,CD,Congo - Kinshasa,541,CD-06,Katanga,8,CD-06-03,Katanga
803,RUE PUC  OCB  RdC 2018,1,CD,Congo - Kinshasa,,,,,,
212,S - None -  -  - Support methodologique -  -  -  -  -,,,,,,,,,
383,SAB Hep C  2014  OCG,76,CH,Switzerland,,,,,,
261,SAB VIH,3,FR,France,,,,,,
173,Safety of the oral cholera vaccine Shanchol in pregnant women,16,GN,Guinea,,,,,,
463,Salarie - Contribution annuelle -DASO,3,FR,France,,,,,,
464,Salarie Epicentre - Contribution annuelle - DEIF,3,FR,France,,,,,,
466,Salarie Epicentre - Contribution annuelle - DESP,3,FR,France,,,,,,
465,Salarie Epicentre - Contribution annuelle - DG,3,FR,France,,,,,,
455,SAMBA,,,,,,,,,
781,SAMBA 2 equivalence study-Uganda - OCP,13,UG,Uganda,3234,UG-03,Arua,49,UG-03-02,Arua
640,SAMBA 2 equivalence study-Uganda (UNITAID VIA OCP),13,UG,Uganda,3234,UG-03,Arua,49,UG-03-02,Arua
634,SAMBA EID pilote introduction - Uganda (via OCP),13,UG,Uganda,3234,UG-03,Arua,49,UG-03-02,Arua
868,Sante maternelle Moissala,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
418,Scanpen support  Ebola  OCG,60,SL,Sierra Leone,2747,SL-04,Western,139,Freetown,Freetown
174,Scientific Advisory Board  Malaria,,,,,,,,,
93,Scientific Advisory Board TB,285,400,Undefined Countries,,,,,,
738,Scientific Day - Uganda,13,UG,Uganda,3247,UG-16,Kampala,50,UG-16-03,Kampala
452,Screening HIV infants Ndhiwa - doublon,14,KE,Kenya,,,,,,
857,Sepsis among HIV-patients  Kabinda  DRC,1,CD,Congo - Kinshasa,542,CD-07,Kinshasa City,10,CD-07-05,Kinshasa
960,Serial CRP to exclude neonatal sepsis,161,GW,Guinea-Bissau,995,GW-03,Bissau,106,Bissau,Bissau
959,Serial CRP to exclude neonatal sepsis - G.Bissau MSF Project,161,GW,Guinea-Bissau,995,GW-03,Bissau,106,Bissau,Bissau
215,Serologic survey of Hepatitis E  Yida  South Sudan,5,SS,South Sudan,2821,SS-06,Unity,82,Yida,Yida
413,Seroprevalence  Ebola  Monrovia  OCP,46,LR,Liberia,,,,,,
839,Seroprevalence of Hepatitis E and arboviral infections (NE114-EPROTH),10,NE,Niger,2078,NE-02,Diffa,34,NE-02-01,Diffa
705,Sex Workers Survey,15,MW,Malawi,2020,MW-21,Nsanje,31,MW-21-02,Nsanje
1024,short oral regimen MDR TB PNG,81,PG,Papua New Guinea,2377,PG-15,National Capital District,114,Port Moresby,Port Moresby
259,Short standard course of DR-TB treatment in Mozambique  MSF-CH (MZ160),22,MZ,Mozambique,,,,,,
651,Simplified regimen for inpatient treatment of neonatal sepsis,285,400,Undefined Countries,,,,,,
735,Simplified regimen for inpatient treatment of neonatal sepsis - Observational cohort study,93,AF,Afghanistan,,,,,,
735,Simplified regimen for inpatient treatment of neonatal sepsis - Observational cohort study,12,NG,Nigeria,,,,,,
398,SMC coverage survey  Guidan Roumdji 2014,10,NE,Niger,,,,,,
396,SMC coverage survey  Koutiala 2014  OCP,8,ML,Mali,,,,,,
397,SMC coverage survey  Moissala 2014,9,TD,Chad,,,,,,
393,SMC Coverage Survey Madarounfa,10,NE,Niger,,,,,,
541,SMC Coverage Surveys for Access SMC  Niger,10,NE,Niger,,,,,,
34,SMC monitoring and coverage  Koutiala  Mali  MSF-F,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
33,SMC monitoring and coverage  Niger  MSF-B,10,NE,Niger,,,,,,
32,SMC monitoring and coverage  Niger  MSF-CH,10,NE,Niger,,,,,,
29,SMC monitoring and coverage  Niger  MSF-E,10,NE,Niger,,,,,,
26,SMC monitoring and coverage  Niger  MSF-F,10,NE,Niger,,,,,,
564,South Sudan - Aweil - Follow up new borns - 2016,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
565,South Sudan - Aweil - Type I diabetes in children - 2016,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
376,South Sudan  Nutrition  Aweil 2013  OCP,5,SS,South Sudan,,,,,,
196,Soutien au departement formation  MSF-OCP,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
253,Statis Trial  Mbarara  ANRS,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
647,suevreillance fievre jaune RDC 2016,1,CD,Congo - Kinshasa,,,,,,
807,Suivi cohorte - Mise a l'echelle Paquets de soins pediatriques - Koutiala - Mali - OCP,8,ML,Mali,1893,ML-08,Sikasso,29,ML-08-01,Koutiala
717,Suivi neonate Katiola,31,CI,Cote d'Ivoire,522,CI-11,Vallee du Bandama,99,Katiola,Katiola
224,Support ad hoc aux operations  MSF-OCG (XO400),76,CH,Switzerland,,,,,,
720,support au PNLP RDC pour OCP,1,CD,Congo - Kinshasa,542,CD-07,Kinshasa City,,,
225,Support aux enquetes terrain  MSF-OCG,76,CH,Switzerland,,,,,,
785,support chapitre 2 guide mauve,3,FR,France,,,,,,
815,Support desk Dubai,285,400,Undefined Countries,,,,,,
837,Support desk Dubai,29,AE,United Arab Emirates,90,AE-03,Dubay,1,AE-03-01,Dubai
703,Support devellopement HIS MSF-OCG (XM400),285,400,Undefined Countries,,,,,,
687,Support Epidemio Cholera OCP - Haiti post ouragan - 2016,7,HT,Haiti,,,,,,
362,Support epidemio palu  rdc  Katanga,1,CD,Congo - Kinshasa,541,CD-06,Katanga,87,Lubumbashi,Lubumbashi
825,Support et developpement de L'epidemiologie pour l'unite d'urgence MSF-OCG (XO500),285,400,Undefined Countries,,,,,,
872,Support evaluation DSD et Self-testing  HIV Kasese,13,UG,Uganda,3252,UG-21,Kasese,51,UG-21-04,Kasese
888,Support Kenya Mission Dagahaley OCG,14,KE,Kenya,,,,,,
528,Support Labo HD Madarounfa,10,NE,Niger,2080,NE-04,Maradi,81,Madarounfa,Madarounfa
861,Support M&E Cell 5 - OCP,1,CD,Congo - Kinshasa,,,,,,
861,Support M&E Cell 5 - OCP,14,KE,Kenya,,,,,,
861,Support M&E Cell 5 - OCP,15,MW,Malawi,,,,,,
861,Support M&E Cell 5 - OCP,13,UG,Uganda,,,,,,
1027,Support M&E mission Kenya OCP,14,KE,Kenya,3232,UG-01,Adjumani,,,
1028,Support M&E mission Ouganda OCP,13,UG,Uganda,3234,UG-03,Arua,,,
1028,Support M&E mission Ouganda OCP,13,UG,Uganda,3252,UG-21,Kasese,,,
92,Support methodo TB ITM,,,,,,,,,
242,Support methodologique  VIH/SIDA,3,FR,France,,,,,,
594,Support methodologique et operationnel  VIH/SIDA,285,400,Undefined Countries,,,,,,
487,Support Operational Research MSF-OCG,285,400,Undefined Countries,,,,,,
581,Support Operational Research MSF-OCG (XM300),285,400,Undefined Countries,,,,,,
770,Support projet rougeole - Katanga OCP,1,CD,Congo - Kinshasa,539,CD-04,Kasai-Occidental,,,
770,Support projet rougeole - Katanga OCP,1,CD,Congo - Kinshasa,541,CD-06,Katanga,,,
437,Support RH epidemio base  OCB,285,400,Undefined Countries,,,,,,
161,Support statistique departement medical  MSF-CH,285,400,Undefined Countries,,,,,,
158,Support Swaziland research team  Nghlangano,17,SZ,Swaziland,2882,SZ-04,Shiselweni,98,Nghlangano,Nghlangano
114,Support TB Lab and TB patients  Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
3,Support technique departement medical  MSF-CH,76,CH,Switzerland,447,CH-08,Geneve,15,CH-08-01,Geneva
601,Support technique departement medical  MSF-OCB,83,BE,Belgium,194,BE-01,Bruxelles,5,BE-01-01,Bruxelles
2,Support technique departement medical  MSF-OCB,285,400,Undefined Countries,,,,,,
523,Support technique pour monitoring du programme CPS a Magaria,10,NE,Niger,,,,,,
48,Support to Lab Working Group  intersection,285,400,Undefined Countries,,,,,,
732,Support to Monitoring of HIV projects - OCP (Kenya  Malawi  Uganda  CAR),4,CF,Central African Republic,,,,,,
732,Support to Monitoring of HIV projects - OCP (Kenya  Malawi  Uganda  CAR),14,KE,Kenya,,,,,,
732,Support to Monitoring of HIV projects - OCP (Kenya  Malawi  Uganda  CAR),15,MW,Malawi,,,,,,
732,Support to Monitoring of HIV projects - OCP (Kenya  Malawi  Uganda  CAR),13,UG,Uganda,,,,,,
132,Support to MSF-OCP surgery projects,,,,,,,,,
607,Support to MSF-OCP surgery projects,,,,,,,,,
889,Support to NY office,285,400,Undefined Countries,,,,,,
135,Support to NY Office,285,400,Undefined Countries,,,,,,
603,Support to NY Office,285,400,Undefined Countries,,,,,,
561,Support to OCG in Mozambic and Swaziland,22,MZ,Mozambique,,,,,,
856,Support to RIDER,285,400,Undefined Countries,,,,,,
958,Support to vaccination with rVSV  Kivu  RDC (CD473),1,CD,Congo - Kinshasa,543,CD-08,Kivu,110,Butembo,Butembo
615,Support to Water and Sanitation  MSF-OCP,3,FR,France,,,,,,
5,Support to Water and Sanitation  MSF-OCP,285,400,Undefined Countries,,,,,,
721,Support Urgences Calais CAO - OCP,3,FR,France,898,FR-04,Ile-de-France,19,FR-04-02,Paris
566,Surgical Outcomes in Gaza,25,PS,Palestine  state of,,,,,,
577,Surgical Outcomes in Gaza,25,PS,Palestine  state of,,,,,,
395,Surveilance - Marburg epidemic Uganda - OCP,13,UG,Uganda,,,,,,
21,Surveillance and survey on water and sanitation in Kalemie  DRC,1,CD,Congo - Kinshasa,541,CD-06,Katanga,7,CD-06-02,Kalemie
420,Surveillance Ebola  Mali  OCP,8,ML,Mali,,,,,,
1061,Surveillance epidemiologique  OCBa,,,,,,,,,
12,Surveillance epidemiologique et production des cartes hebdomadaires  Haiti  OCP,7,HT,Haiti,1139,HT-01,Centre,76,Port au prince,Port au prince
771,Surveillance hepatite E  Diffa  Niger,10,NE,Niger,2078,NE-02,Diffa,34,NE-02-01,Diffa
847,Surveillance intersection meningite/rougeole au Niger 2018,10,NE,Niger,,,,,,
540,surveillance LRTI - Yida  Adjumani  Gambella,75,ET,Ethiopia,,,,,,
540,surveillance LRTI - Yida  Adjumani  Gambella,5,SS,South Sudan,,,,,,
540,surveillance LRTI - Yida  Adjumani  Gambella,13,UG,Uganda,,,,,,
23,Surveillance meningite  Moissala  OCP,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
613,Surveillance meningite  Moissala  OCP,9,TD,Chad,2941,TD-13,Mandoul,47,TD-13-01,Moissala
719,Surveillance meningite/rougeole intersection au Niger,10,NE,Niger,,,,,,
527,Surveillance paludisme Tchad post CPS,9,TD,Chad,,,,,,
22,Surveillance prospective de la mortalite en communaute  Carnot  RCA,4,CF,Central African Republic,417,CF-08,Mambere-Kadei,13,CF-08-01,Carnot
188,Surveillance rotavirus  Massakory  Tchad  MSF-CH,9,TD,Chad,2936,TD-08,Hadjer-Lamis,92,Massakory,Massakory
609,Surveillance rotavirus  Massakory  Tchad  MSF-CH,9,TD,Chad,2936,TD-08,Hadjer-Lamis,92,Massakory,Massakory
814,Survey on Attack rate and mortality rate of cholera in Yemen,33,YE,Yemen,3545,YE-14,Ibb,,,
658,surveys in diificult to reach populations,285,400,Undefined Countries,,,,,,
795,Syria  Atmeh CHW surveillance training and Survey,32,SY,Syria,2918,SY-10,Idlib,46,SY-10-02,Atmeh
683,Syrian Medical Support Data analysis  Review,32,SY,Syria,,,,,,
83,Systematic amoxicillan vs. placebo in non-complicated SAM,10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
217,Systematic clinical description of suspected rickets cases  Yemen,33,YE,Yemen,,,,,,
350,Systematic TB treatment in malnourished  OCBA,,,,,,,,,
349,Systematic TB treatment in malnourished  OCG,,,,,,,,,
348,Systematic TB treatment in malnourished  OCP,,,,,,,,,
304,Systematic TB treatment in severe malnourished children,285,400,Undefined Countries,,,,,,
145,Systematic use of TB-LAM test (Determine ) in HIV infected adults with low CD4 count,,,,,,,,,
320,Systeme de surveillance mortalite  Bangui  RCA  MSF-B,4,CF,Central African Republic,411,CF-02,Bangui,97,Bangui,Bangui
202,T - Training -  -  - Formation des Cadres - Session 1/Avril - MSF-F -  -  -  -,3,FR,France,,,,,,
203,T - Training -  -  - Formation des Cadres - Session 2/Octobre - MSF-F -  -  -  -,3,FR,France,,,,,,
192,T - Training - All -  - PSP1 February 2013 - MSF-F - MSF-B - MSF-CH - MSF-H - MSF-E,,,,,,,,,
193,T - Training - All -  - PSP2 September 2013 - MSF-F - MSF-B - MSF-CH - MSF-H - MSF-E,,,,,,,,,
194,T - Training - All -  - Rep. Aux Epid. Anglais - MSF-F - MSF-B - MSF-CH - MSF-H - MSF-E,,,,,,,,,
195,T - Training - All -  - Rep. Aux Epid. Francais - MSF-F - MSF-B - MSF-CH - MSF-H - MSF-E,,,,,,,,,
199,T - Training - All -  - Revision du PSP - MSF-F -  -  -  -,,,,,,,,,
207,T - Training - Australie - Sydney - E-Response training course - MSF-F -  -  -  -,26,AU,Australia,,,,,,
205,T - Training - France - Creteil - University course - U. Creteil -  -  -  -,3,FR,France,,,,,,
206,T - Training - France - Rennes - University course - U. Rennes -  -  -  -,3,FR,France,,,,,,
204,T - Training - Ouganda - Kampala - Reponse aux urgences et aux epidemies - MSF-CH -  -  -  -,13,UG,Uganda,,,,,,
201,T - Training - Tchad -  - Reponse aux epidemies - MSF-F -  -  -  -,9,TD,Chad,,,,,,
777,Task shifting in HIV programs - OCP,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
287,Task shifting in HIV programs  UNITAID,15,MW,Malawi,,,,,,
494,Task shifting in HIV programs  UNITAID (via OCP),15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
765,TB-SPEED UNITAID,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
249,TB diagnosis of acutely ill children  Mbarara,13,UG,Uganda,3270,UG-39,Mbarara,52,UG-39-05,Mbarara
214,Technical follow up data collection  intersection  Syria,32,SY,Syria,,,,,,
190,Technical support in External Quality Control  DNDI,13,UG,Uganda,,,,,,
508,test,3,FR,France,,,,,,
483,Test and Treat Evaluation South Sudan,5,SS,South Sudan,,,,,,
584,Test and Treat Evaluation South Sudan,5,SS,South Sudan,,,,,,
170,Tests diagnostiques rapides  Institut Pasteur et MSF-OCP,285,400,Undefined Countries,,,,,,
787,Texas Explo,30,US,United States,3388,US-44,Texas,134,Houston,Houston
79,Time to become negative of three rapid diagnostic tests for malaria in children under 5 years of age,13,UG,Uganda,,,,,,
341,Training_ResponseToEmergencies_OCB_Pakistan_2014,,,,,,,,,
309,Treatment of cholera-related emesis to improve the benefits of ORS therapy,,,,,,,,,
593,Treatment of cholera-related emesis to improve the benefits of ORS therapy,,,,,,,,,
722,Typologie annuelle  BI,285,400,Undefined Countries,,,,,,
366,Uganda  Carriage  Adjumani  2014,13,UG,Uganda,,,,,,
691,Uganda Bidibidi evaluation initiale - OCP,13,UG,Uganda,3289,UG-58,Yumbe,69,Yumbe,Yumbe
306,Ultrasound Guided Peripheral Nerve Blocks,,,,,,,,,
725,Understanding of the aetiology and pathophysiology of kwashiorkor OR15/27,10,NE,Niger,2080,NE-04,Maradi,81,Madarounfa,Madarounfa
725,Understanding of the aetiology and pathophysiology of kwashiorkor OR15/27,10,NE,Niger,2080,NE-04,Maradi,35,NE-04-02,Maradi
239,Unitaid funded - POC  M&E  Impact  Feasibility  Outcome,285,400,Undefined Countries,,,,,,
288,UNITAID Viral Load: Association between NNRTI exposure  VL suppression and emergence of resistance in HIV-infected patients on rifampicin (CARINEMO),22,MZ,Mozambique,,,,,,
1056,Urgence cholera - Lubumbashi - RDC- MSF OCP,1,CD,Congo - Kinshasa,541,CD-06,Katanga,87,Lubumbashi,Lubumbashi
961,Urgepi - Lubumbashi - RDC - OCP,1,CD,Congo - Kinshasa,541,CD-06,Katanga,87,Lubumbashi,Lubumbashi
684,Use of Hepatitis E vaccine,10,NE,Niger,2078,NE-02,Diffa,34,NE-02-01,Diffa
750,Use of LAM for the diagnosis of tuberculosis in RDC,1,CD,Congo - Kinshasa,542,CD-07,Kinshasa City,10,CD-07-05,Kinshasa
595,Use of LAM test in adults  Chiradzulu  OCP,15,MW,Malawi,2003,MW-04,Chiradzulu,30,MW-04-01,Chiradzulu
346,Use of LAM test in adults  Chiradzulu  OCP,15,MW,Malawi,,,,,,
345,Use of LAM test in adults  Maputo  OCG,22,MZ,Mozambique,,,,,,
598,Use of LAM test in adults  Maputo  OCG (MZ160),22,MZ,Mozambique,1962,MZ-06,Maputo,32,MZ-06-01,Maputo
347,Use of LAM test in adults  Myanmar  OCG,21,MM,Myanmar (Burma),,,,,,
303,Use of LAM test in HIV infected adults with low CD4 count in programmatic conditions  OCP,87,MK,Macedonia,,,,,,
256,Use of measles vaccine in a controlled temperature chain (CTC),1,CD,Congo - Kinshasa,,,,,,
726,Use of measles vaccine in Controlled Temperature Chain,1,CD,Congo - Kinshasa,,,,,,
401,Use of pegylated liposomal doxorubicin for treatment of Kaposi's Sarcoma  OCG (MZ160),22,MZ,Mozambique,1962,MZ-06,Maputo,32,MZ-06-01,Maputo
119,Use of tetanos vaccine out of the cold chain,9,TD,Chad,,,,,,
453,UZIMA,13,UG,Uganda,,,,,,
216,Vaccination coverage and effectiveness of OCV  Kalemie  RDC,1,CD,Congo - Kinshasa,541,CD-06,Katanga,7,CD-06-02,Kalemie
233,Vaccine Coverage and Effectiveness Protocols for Oral Cholera Vaccine,,,,,,,,,
654,vaccine coverage survey and nutritionnal evaluation using MUAC  Aweil Town  South Sudan,5,SS,South Sudan,2820,SS-05,North Bahr-al-Ghazal,44,SS-05-02,Aweil
165,Vaccine effectiveness of one dose of the OCV Shanchol: concept paper and protocol development,285,400,Undefined Countries,,,,,,
392,Vaccinecoverage_PCV_Adjumani_Uganda_2014,13,UG,Uganda,3232,UG-01,Adjumani,48,UG-01-01,Adjumani
99,Variability of DST for ethambutol and mutations implicated in resistance  Georgia,89,GE,Georgia,,,,,,
467,VASCOMU: Validation of a clinical score for the diagnosis of Mycobacterium ulcerans (MU) infection in Cameroon,45,CM,Cameroon,,,,,,
583,VASCOMU: Validation of a clinical score for the diagnosis of Mycobacterium ulcerans (MU) infection in Cameroon (MI984),45,CM,Cameroon,526,CM-01,Adamaoua,,,
583,VASCOMU: Validation of a clinical score for the diagnosis of Mycobacterium ulcerans (MU) infection in Cameroon (MI984),45,CM,Cameroon,527,CM-02,Centre,,,
1066,VC survey protocol-template in french for submission MSF ERB,,,,,,,,,
391,Villagebasedsurveillance_Ebola_Loffa_Liberia_OCG,46,LR,Liberia,,,,,,
338,Violence  Bangui  intersectional  RCA  2014,4,CF,Central African Republic,411,CF-02,Bangui,97,Bangui,Bangui
542,Viral Load: Association between NNRTI exposure  VL suppression and emergence of resistance in HIV-infected patients on rifampicin (CARINEMO) (UNITAID via OCB),22,MZ,Mozambique,,,,,,
641,VL_4country_support_consortium,75,ET,Ethiopia,,,,,,
537,VL_4country_support_consortium,,,,,,,,,
579,VL_4country_support_consortium,,,,,,,,,
382,Voyage Unitaid Hep C,56,IN,India,,,,,,
382,Voyage Unitaid Hep C,55,IR,Iran,,,,,,
382,Voyage Unitaid Hep C,14,KE,Kenya,,,,,,
382,Voyage Unitaid Hep C,22,MZ,Mozambique,,,,,,
382,Voyage Unitaid Hep C,13,UG,Uganda,,,,,,
382,Voyage Unitaid Hep C,57,UA,Ukraine,,,,,,
399,WHO OCV Guideline,285,400,Undefined Countries,,,,,,
381,Wound survey  OCP,1,CD,Congo - Kinshasa,,,,,,
591,Wound survey  OCP,1,CD,Congo - Kinshasa,,,,,,
605,Xpert diagnostic algorithm  Homa Bay,14,KE,Kenya,1461,KE-08,Homa Bay,26,KE-08-01,Homa Bay
100,Xpert diagnostic algorithm  Homa Bay,14,KE,Kenya,,,,,,
646,Yellow fever _ Uganda _2016,13,UG,Uganda,,,,,,
445,Yida  support vaccine coverage 2014  OCP,5,SS,South Sudan,2821,SS-06,Unity,82,Yida,Yida
